Search
The expanding horizon of anti-IL-36 therapy
By Warren R. Heymann, MD, FAAD Sept. 25, 2024 Vol. 6, No. 39 An abridged version of this commentary was published in "A Clinician’s Perspective" in the April 2024 issue of the JAAD ... . We last explored the relationship between IL-36 and generalized pustular psoriasis (GPP) and the use
Neurofibromatosis type 1, juvenile xanthogranuloma, and leukemia: Wasting a good worry?
By Warren R. Heymann, MD May 22, 2017 A clinically pigmented neurofibroma associated with underlying café au lait macule. ... Credit: ... JAAD Worry comes with the territory of Neurofibromatosis Type I (NF-1). It often starts with the anxiety of determining if a child has enough criteria to confirm the
Session handouts and meetings archive
Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation
CME & session evaluation archive
Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2026 Annual Meeting, Denver, CO, March 27-31, 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual
Glomus tumors point a finger at neurofibromatosis
By Warren R. Heymann, MD ... Nov. 21, 2016 ... The correct diagnosis of the ... JAMA Dermatology Clinicopathological Correlation of a glomus tumor presenting as longitudinal erythronychia was straightforward — I was fascinated by this comment in the discussion: "The presence of multiple glomus tumors in the digits
Are you at risk for pityriasis rubra type V? It’s in the cards!
By Warren R. Heymann, MD Feb. 1, 2017 Characteristic facial involvement in caspase recruitment domain family member 14 gene (CARD14)-associated papulosquamous eruption. Symmetric and geometric pink, scaly patches or plaques involving the cheeks, upper cutaneous lip, and chin with sparing of the infralabial region is highly characteristic of CARD14-associated papulosquamous
IL-36 and generalized pustular psoriasis: L’chaim!
By Warren R. Heymann, MD, FAAD March 9, 2022 Vol. 4, No. 10 In 1910, Leo Ritter von Zumbusch meticulously detailed the clinical course of "psoriasis pustulosa generalisata" (referred to herein as generalized pustular psoriasis, GPP) in a brother and sister, pondering if this was a variant of psoriasis or
Weighing in on glucagon-like peptide-1 receptor agonists in dermatology
By Warren R. Heymann, MD, FAAD April 17, 2024 Vol. 6, No. 16 Glucagon-like peptide-1 (GLP-1) receptor agonists — your patients are on them, and perhaps you are too (or at least have thought about it). In 2023, more than 500 million people worldwide were afflicted with obesity and type
Melanoma risk in patients with melaoncortin-1 receptor independent of ultraviolet radiation: Is there a way not to be burned by your genome?
By Warren R. Heymann, MD July 18, 2016 I admit that my concept of Type I skin red-headed patients getting melanoma was simple: They have a polymorphism(s) of the melanocortin-1 receptor (MC1R), pheomelanin, ultraviolet exposure, DNA damage, increased reactive oxygen species, and voila: melanoma! While conceptually elegant, this is apparently
Secukinumab for pityriasis rubra pilaris: Tread lightly
By Warren R. Heymann, MD Nov. 17, 2016 Every dermatology resident preparing for their board examination can rattle off Griffiths’ classification of pityriasis rubra pilaris (PRP) — Type I (Classical Adult), Type II (Atypical Adult), Type III (Classic Juvenile), Type IV (Circumscribed Juvenile), and Type V (Atypical Juvenile). Type VI,
AADA hosts largest Capitol Hill skin cancer check in a decade
On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.
Perspectives on peristomal pyoderma gangrenosum
By Warren R. Heymann, MD Oct. 28, 2016 Peristomal pyoderma gangrenosum (PPG) is a challenging problem, both physically and emotionally. The diagnosis may be delayed, often being mistaken for an irritant dermatitis or an infection. Barbosa et al have performed an extensive review of their experience in 44 patients
An incisive approach to chronic paronychia: The square flap technique
By Warren R. Heymann, MD Aug. 2, 2016 I cannot begin to guess how many patients I have seen with chronic paronychia (CP) since I started my residency 36 years ago. I know precisely how many patients I have referred for surgical correction of CP — zero! The reason for
Getting a leg up on squamous cell carcinomas of the teratoacanthoma type
By Warren R. Heymann, MD Oct. 8, 2016 I thought it was my imagination, but apparently not — there is distinct subset of patients, mostly mature women, with squamous cell carcinomas (SCC) of the keratoacanthoma type (KA) usually presenting on the anterior distal lower extremities. ... These patients are not
Other emerging severe and resistant dermatophytes of concern
Overview ... Trichophyton mentagrophytes type VII (TMV ... II ... ) is a recently emerged dermatophyte that is closely related to ... T. indotineae (note: ... T. indotineae was previously called ... T. mentagrophytes type ... VIII ... ). ... 1-3 ... TMVII spreads between people and may be transmitted
Decomplexing plexiform neurofibromas
By Warren R. Heymann, MD Dec. 29, 2016 Plexiform neurofibromas (PNs) are some of the most disfiguring and therapeutically challenging lesions that dermatologists confront. PNs are mostly associated with autosomal dominant neurofibromatosis type 1. Rarely, they may also be seen in germline p16 mutation-positive heritable melanoma and Cowden syndrome. Diffuse
Multiple café au lait spots in fair skinned children without evidence of neurofibromatosis type 1: Don’t SPRE(A)D the word – yet
By Warren R. Heymann, MD Oct. 13, 2016 Café au lait spots (CALS) are extraordinarily common; six or more lesions (at least 0.5 cm prior to puberty or 1.5 cm post puberty) are considered one of the criteria for diagnosing neurofibromatosis type I (NF1), and are also seen in
Medical research funding
Ask the Expert ... By Victoria Houghton, managing editor, August 1, 2021 DermWorld ... spoke to Jennifer Mangone, JD, manager of congressional policy for the American Academy of Dermatology Association (AADA), about the Academy’s advocacy efforts to support medical research funding. DermWorld: Advocating for medical research funding is a top
Incretin-based therapy for diabetes and dermatology: Promise and peril
By Warren R. Heymann, MD Oct. 23, 2017 In a given day, how many of your patients are diabetic? According to the American Diabetes Association, in 2015, 9.4% of the US population (30.3 million) were diabetic; 29 million of this group had type 2 diabetes. ... Incretin hormones refer to
Plantar melanoma and mechanical stress
By Warren R. Heymann, MD June 15, 2016 Acral lentiginous melanoma (ALM) involves the palms, soles, and nail beds. It is the most common type of melanoma in patients of African or Asian descent. Delays in diagnosis result in more advanced disease at the time of diagnosis. Trauma or chronic
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention ... DESCRIPTION: The percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period and who received tobacco cessation intervention during the measurement period or in the six months
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention ... DESCRIPTION: The percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period and who received tobacco cessation intervention during the measurement period or in the six months
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon – Part II – Focus on Anifrolumab
By Warren R. Heymann, MD, FAAD Sept. 13, 2023 Vol. 5, No. 37 This is an exciting time for cutaneous lupus erythematosus (CLE). Recently published findings from three clinical trials show substantial progress in developing more targeted, efficacious, and better-tolerated medications for patients with CLE, particularly by inhibiting the production
Dermatology doubles media presence in 2020
Facts at your fingertips ... By Emily Margosian, assistant editor, August 1, 2021 Last year, dermatology-related topics generated a record-breaking 36 billion print, broadcast, and online media impressions — more than double the total coverage in 2019. This sharp increase is likely tied to COVID-19, specifically news items on COVID-related
Prior authorization’s impact on patients
Facts at your fingertips ... By Emily Margosian, assistant editor, September 1, 2020 While prior authorizations are often applied to biologics, the process also includes less expensive medication options and procedures, with a profound impact on many dermatology patients. Results from the AAD’s 2020 Prior Authorization Survey reveal that about
Will PD-1 inhibitors be msed for Mastocytosis?
By Warren R. Heymann, MD May 8, 2016 Kuklinski L, Kim J. Expression of PD-L1 in mastocytosis. J Am Acad Dermatol 2016; 74: 1010-2. ... The authors evaluated 16 specimens from 12 patients with mastocytosis, using immunohistochemical stains for PD-L1, CD-117, and mast cell tryptase on all specimens. Of the12
Where do Americans get pricing information for health care services?
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, November 1, 2022 New survey data released this year by Akasa, a health care AI developer, found that Americans most often turn to health insurers for pricing information over other sources, placing new emphasis on the need for price transparency
Early-onset hypertension associated with extensive capillary malformations: A new worry to raise dermatologists’ blood pressure
By Warren R. Heymann, MD, FAAD Jan. 31, 2024 Vol. 6, No. 5 The recent passing of Mikhail Gorbachev reminded me of the teaching value of his port wine stain. The following brief article published in the ... Washington Post in 1987 reflects the state of knowledge 36 years ago.
October 12, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 12, 2022 ... Type 2 diabetes and CCCA severity DermWorld Insights and Inquiries : Fixing the concept of the neutrophilic fixed drug eruption What’s the risk of IBD in patients
ICD-10-CM diagnosis coding updates for 2025
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, October 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . The Centers for Disease Control and
Do skin cancer rates differ by transplanted organ type and patient age?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, March 1, 2023 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Lee Wheless, MD,
Key messaging in social media about acne
Key messages ... Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. (1) ... There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules), so a one-size-fits-all approach is not the best way to achieve clearer skin. (1)
March 9, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 9, 2022 ... Eight misconceptions about photoprotection in skin of color DermWorld Insights and Inquiries : IL-36 and generalized pustular psoriasis — L’chaim! Derm Coding Consult : Novitas revises shave
Paraneoplastic Merkel cell carcinoma: Searchin’ for my lost shaker of salt
By Warren R. Heymann, MD, FAAD Sept. 6, 2023 Vol. 5, No. 36 By pure coincidence, Jimmy Buffett passed away from Merkel cell carcinoma (MCC) as I researched the topic of paraneoplastic MCC. Although I am no parrothead, every time I’d hear Margaritaville, I’d smile and fantasize about a lifestyle
September 25, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / September 25, 2024 ... Cyclosporine vs. dupilumab vs. methotrexate for patients with AD DermWorld Insights and Inquiries : The expanding horizon of anti-IL-36 therapy FDA approves new treatment for immune-mediated vasculitis
Skin conditions by the numbers
Acne ... Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. (1) ... There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules), so a one-size-fits-all approach is not the best way to achieve clearer skin. (2) A
Research grants from outside organizations
Numerous organizations offer funding to support research in dermatology. The AAD has collected the information below to help members who may seek financial support for their research efforts. ... American Skin Association (ASA) Established 36 years ago to serve the now more than 100 million Americans afflicted with skin disorders,
Caveat mTOR revisited: Neurofibromatosis
By Warren R. Heymann, MD, FAAD Feb. 14, 2024 Vol. 6, No. 7 An abridged version of this commentary was published in "A Clinician's Perspective" in the April 2023 issue of the JAAD. ... It is understandable how dermatologists may forget about many details of rare genodermatoses after taking their
Screening firefighters for skin cancer
First Person ... By Christine Kannler, MD, FAAD, October 1, 2022 DermWorld’s ... First Person column offers Academy members the opportunity to share their personal reflections about how dermatology is changing and how they’ve adapted. Christine Kannler, MD, FAAD ... My brother was a firefighter in Chelsea, Massachusetts, an instructor
Becoming pro-geriatric by understanding progeria
By Warren R. Heymann, MD Aug. 13, 2018 A fifteen-year-old boy with Hutchinson-Gilford progeria syndrome. ... Credit: ... JAAD I have never seen a case of Hutchinson-Gilford progeria syndrome (HGPS). You probably haven’t either, given its incidence of 1 in 4 million. Why comment on a disease that will likely
Cannabinoids may elevate therapy for connective tissue diseases to a higher level
By Warren R. Heymann, MD Nov. 2, 2017 Medical "reefer madness" is taking hold in the United States with approximately 10% of cannabis users utilizing it for diverse medical conditions, including dermatologic disorders such as pruritus and atopic dermatitis. To date, at least 28 states allow for the use of
Melanoma: Tracking and Evaluation of Recurrence — Measure 509
Melanoma: Tracking and Evaluation of Recurrence ... DESCRIPTION: Percentage of patients who had an excisional surgery for melanoma or melanoma in situ with initial American Joint Committee on Cancer (AJCC) staging of 0, I, or II, in the past 5 years in which the operating provider examines and/or diagnoses the
Melanoma: Tracking and Evaluation of Recurrence — Measure 509
Melanoma: Tracking and Evaluation of Recurrence ... DESCRIPTION: Percentage of patients who had an excisional surgery for melanoma or melanoma in situ with initial American Joint Committee on Cancer (AJCC) staging of 0, I, or II, in the past 5 years in which the operating provider examines and/or diagnoses the
Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503
Gains in Patient Activation Measure (PAM®) Scores at 12 Months ... DESCRIPTION: The Patient Activation Measure (PAM) is a 10- or 13-item questionnaire that assesses an individual’s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to one
Reporting excimer laser therapy: When to use 96999 vs 9692x
As a result of a code descriptor change for CPT codes 96920-96922 effective Jan. 1, 2024, these codes are now to be used only for excimer laser treatment of psoriasis. This change was made by the AMA CPT to better align with the intended use of these services exclusively for
Twenty-first century pellagra
By Warren R. Heymann, MD, FAAD Sept. 10, 2025 Vol. 7, No. 36 With obesity (defined as a body mass index > 30) affecting more than 40% of the adult population of the United States (1), it is difficult to fathom that nutritional deficiencies still exist. Kiani et al. expertly
Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503
Gains in Patient Activation Measure (PAM®) Scores at 12 Months ... DESCRIPTION: The Patient Activation Measure (PAM) is a 10- or 13-item questionnaire that assesses an individual’s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to one
The naked truth about total body skin examination: A lesson from Goldilocks and the Three Bears
By Lorraine L. Rosamilia, MD Nov. 13, 2019 Vol. 1, No. 36 In my last 13 years of immersion in dermatology, I have often asked this simple yet elusive question of my superiors, my colleagues, and myself: Which patients need skin checks? As I peruse my clinical schedule, in which
COVID-19 can nail you in so many ways
By Elizabeth Yim, MD, MPH, FAAD, and John Montgomery Yost, MD, MPH, FAAD July 13, 2022 Vol. 4, No. 28 Dr. Elizabeth Yim and Dr. John M. Yost. ... During these difficult and quite frankly, scary times, we have heard numerous reports of various cutaneous manifestations by the SARS-COV-2 infection
August 1
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / AUGUST 1, 2018 ... Physicians suing patients over negative reviews FDA to laser device manufacturers: Stop marketing for vaginal rejuvenation FDA releases biosimilars plan to increase access, encourage competition Blood test
The “rope” sign is knot pathognomonic: Autoimmunity ties the etiologies together
By Warren R. Heymann, MD July 8, 2016 The "rope" sign is a dramatic finding presenting as a linear to curvilinear cords ("cordonifom") on the lateral chest. It was originally described as an uncommon, but specific feature of Interstitial Granulomatous Dermatitis with Arthritis (IGDA), and has been considered pathognomonic for
Screening for Social Drivers of Health — Measure 487
Screening for Social Drivers of Health ... DESCRIPTION: Percent of patients 18 years and older screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety. ... ... MEASURE ID: ... 487 ... ... Type: Process ... ... CMS Derm Specialty Set: ...
Melanoma Reporting — Measure 397
Melanoma Reporting ... DESCRIPTION: The number of pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration, mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. ... ... MEASURE ID: ... 397 ... ... Type: Process
Melanoma Reporting — Measure 397
Melanoma Reporting ... DESCRIPTION: The number of pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration, mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. ... ... MEASURE ID: ... 397 ... ... Type: Process
Documentation of Current Medications in the Medical Record — Measure 130
Documentation of Current Medications in the Medical Record ... DESCRIPTION: Percentage of visits for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. ... ... MEASURE ID: ... 130 ...
Documentation of Current Medications in the Medical Record — Measure 130
Documentation of Current Medications in the Medical Record ... DESCRIPTION: Percentage of visits for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. ... ... MEASURE ID: ... 130 ...
Closing the Referral Loop: Receipt of Specialist Report — Measure 374
Closing the Referral Loop: Receipt of Specialist Report ... DESCRIPTION: The percentage of patients with referrals during the reporting period whose referring physician received a report back from the other physician. ... ... MEASURE ID: ... 374 ... ... Type: Process ... ... CMS Derm Specialty
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented — Measure 317
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented ... DESCRIPTION: Percentage of adult patients who were screened for high blood pressure and received a follow-up plan where indicated. ... ... MEASURE ID: ... 317 ... ... Type: Process ... ... CMS Derm
Adult Immunization Status — Measure 493
Adult Immunization Status ... DESCRIPTION: Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; pneumococcal; and hepatitis B. ... ... MEASURE ID: ... 493 ... ...
Patient-Centered Surgical Risk Assessment and Communication — Measure 358
Patient-Centered Surgical Risk Assessment and Communication ... DESCRIPTION: The percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed and discussed prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with the surgeon. ...
Patient-Centered Surgical Risk Assessment and Communication — Measure 358
Patient-Centered Surgical Risk Assessment and Communication ... DESCRIPTION: The percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed and discussed prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with the surgeon. ...
Adult Immunization Status — Measure 493
Adult Immunization Status ... DESCRIPTION: Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; and pneumococcal. ... ... MEASURE ID: ... 493 ... ... Type: Process
Looking beyond ‘Ozempic face’
Dermatologists weigh in on cutaneous side effects of GLP-1 agonists. ... Feature ... By Emily Margosian, Senior Editor, November 1, 2025 Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body
Closing the Referral Loop: Receipt of Specialist Report — Measure 374
Closing the Referral Loop: Receipt of Specialist Report ... DESCRIPTION: The percentage of patients with referrals during the reporting period whose referring physician received a report back from the other physician. ... ... MEASURE ID: ... 374 ... ... Type: Process ... ... CMS Derm Specialty
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis ... DESCRIPTION: Percentage of patients with a diagnosis of severe psoriasis without a documented Body Surface Area (BSA) or a documented BSA greater than 10% for whom phototherapy or an oral systemic or biologic medication was prescribed. ... ... MEASURE ID:
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis ... DESCRIPTION: Percentage of patients with a diagnosis of severe psoriasis without a documented Body Surface Area (BSA) or a documented BSA greater than 10% for whom phototherapy or an oral systemic or biologic medication was prescribed. ... ... MEASURE ID:
Periocular hypopigmentation of the elderly: A new POTUS dermatosis?
By Warren R. Heymann, MD, FAAD Sept. 4, 2024 Vol. 6, No. 36 Editorial Note: DermWorld Insights and Inquiries provides commentaries on issues in dermatology. This editorial was composed before the assassination attempt of former President Trump, President Biden’s decision not to seek a second term, and the nomination of
Use of High-Risk Medications in Older Adults — Measure 238
Use of High-Risk Medications in Older Adults ... DESCRIPTION: Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class. ... ... MEASURE ID: ... 238 ... ... Type: Process ... ... CMS Derm Specialty
Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12
Melanoma: Appropriate Surgical Margins ... DESCRIPTION: Percentage of primary excisional surgeries for melanoma or melanoma in situ with Breslow depth and appropriate surgical margins per the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-Melanoma (NCCN Guideline). ... ... MEASURE ID: ... AAD12 ... ... Type: Intermediate
Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6
Skin Cancer: Biopsy Reporting Time — Clinician to Patient ... DESCRIPTION: The percentage of patients with skin biopsy specimens with a diagnosis of cutaneous basal, squamous cell carcinoma, or melanoma (including in situ disease), or primary cutaneous malignancies who are notified of their final biopsy pathology findings within less than
Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6
Skin Cancer: Biopsy Reporting Time — Clinician to Patient ... DESCRIPTION: The percentage of patients with skin biopsy specimens with a diagnosis of cutaneous basal, squamous cell carcinoma, or melanoma (including in situ disease), or primary cutaneous malignancies who are notified of their final biopsy pathology findings within less than
Psoriasis: Clinical Response to Systemic Medications — Measure 410
Psoriasis: Clinical Response to Systemic Medications ... DESCRIPTION: The percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician- or patient-reported disease activity levels. ... ... MEASURE ID: ... 410 ... ... Type: Outcome ... ... CMS Derm Specialty Set: ... Yes ...
Controlling High Blood Pressure — Measure 236
Controlling High Blood Pressure ... DESCRIPTION: Percentage of patients 18–85 years of age who had a diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period, and whose most recent blood pressure was adequately controlled (<140/90 mmHg) during the measurement
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience — QCDR measure AAD 20
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience ... DESCRIPTION: Percentage of adult patients (age 18 years and older) who report favorable outcomes resulting from a recommended treatment or management approach for Actinic Keratosis. Patients provide a global assessment of the perceived effectiveness
Psoriasis: Clinical Response to Systemic Medications — Measure 410
Psoriasis: Clinical Response to Systemic Medications ... DESCRIPTION: The percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician- or patient-reported disease activity levels. ... ... MEASURE ID: ... 410 ... ... Type: Intermediate outcome ... ... CMS Derm Specialty Set: ... Yes
Alarming but benign: The enigma of acute hemorrhagic edema of infancy
By Warren R. Heymann, MD, FAAD Sept. 8, 2021 Vol. 3, No. 36 "The patient, a fat baby thriving on its mother’s milk, was suddenly attacked by purpura, urticaria and localized edema, lasting about ten days. There were only systemic symptoms from the result of pain. At first the bowels
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling ... DESCRIPTION: The percentage of adult patients who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months and received brief counseling if identified as an unhealthy alcohol user. ...
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling ... DESCRIPTION: The percentage of adult patients who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months and received brief counseling if identified as an unhealthy alcohol user. ...
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes — QCDR measure AAD 20
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes ... DESCRIPTION: Percentage of adult patients (18 years old and older) who self-report favorable outcomes resulting from a recommended treatment or management approach for Actinic Keratosis (AK) and who self-report satisfaction with the treatment or management of AK. Patients provide a global
How to treat a sunburn
Board-certified dermatologist shares 5 tips for Skin Cancer Awareness Month ROSEMONT, Ill. (May 21, 2024) — Sunburns can be painful and damaging to your skin, while also increasing your risk of skin cancer, the most common cancer in the United States and one of the most preventable. A new survey
Advance Care Plan — Measure 47
Advance Care Plan ... DESCRIPTION: Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the patient did not wish or was not
Advance Care Plan — Measure 47
Advance Care Plan ... DESCRIPTION: Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the patient did not wish or was not
Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8
Chronic Skin Conditions: Patient Reported Quality-of-Life ... DESCRIPTION: The percentage of patients aged 18 years and older with a chronic skin condition whose self-assessed quality-of-life was recorded at least once in the medical record within the measurement period. ... ... MEASURE ID: ... AAD8 ... ... Type:
Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485
Psoriasis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient reported itch severity assessment performed, score greater than or equal to 4, and who achieve a score reduction of
Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486
Dermatitis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of dermatitis where at an initial (index) visit have a patient reported itch severity assessments performed, score greater than or equal to 4, and who achieve a score reduction of
Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD 17
Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer, on prescribed anticoagulation therapy, who had intermediate layer and/or complex linear closures OR reconstruction after skin
Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection — QCDR measure AAD 18
Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection ... DESCRIPTION: Percentage of procedures in patients, aged 18 and older with a diagnosis of skin cancer, who had intermediate layer and/or complex linear closures OR reconstruction after skin cancer resection where opioid/narcotic therapy was prescribed as first
May 1
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 1, 2019 ... FDA approves two new psoriasis treatments ... DW Insights and Inquiries : When assessing morbilliform eruptions think about morbilli (measles)! We want your feedback: Draft psoriasis guidelines
Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440
Skin Cancer: Biopsy Reporting Time — Pathologist to Clinician ... DESCRIPTION: The percentage of biopsies with a diagnosis of cutaneous BCC, SCC, or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within seven days from receipt of the tissue specimen. ... ... MEASURE
Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440
Skin Cancer: Biopsy Reporting Time — Pathologist to Clinician ... DESCRIPTION: The percentage of biopsies with a diagnosis of cutaneous BCC, SCC, or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within seven days from receipt of the tissue specimen. ... ... MEASURE
Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485
Psoriasis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient reported itch severity assessment performed, score greater than or equal to 4, and who achieve a score reduction of
Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486
Dermatitis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of dermatitis where at an initial (index) visit have a patient reported itch severity assessments performed, score greater than or equal to 4, and who achieve a score reduction of
Connection to Community Service Provider — Measure 498
Connection to Community Service Provider ... DESCRIPTION: Percent of patients 18 years and older who screened positive for one or more of the following health-related social needs: food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety and had contact with a Community Service Provider for at least one
Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12
Melanoma: Appropriate Surgical Margins ... DESCRIPTION: Percentage of primary excisional surgeries for melanoma or melanoma in situ with Breslow depth and appropriate surgical margins per the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-Melanoma (NCCN Guideline). ... ... MEASURE ID: ... AAD12 ... ... Type: Intermediate
BASCULE syndrome: Is something brewing with Bier spots?
By Warren R. Heymann, MD, FAAD Sept. 7, 2022 Vol. 4, No. 36 I have never paid too much attention to Bier spots, other than reassuring patients that they are of no concern. I may have been too cavalier by not probing further. ... Classical Bier spots (BS, also referred
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer who underwent intermediate layer, complex linear closure, or reconstruction after skin cancer resection in the office-based setting (not
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer who underwent intermediate layer, complex linear closure, or reconstruction after skin cancer resection in the office-based setting (not
Triskaidekaphobia legitimized: Fatal Factor XIII deficiency
By Warren R. Heymann, MD, FAAD April 12, 2023 Vol. 5, No. 15 I am not especially superstitious. The number 13 has never concerned me but acquired Factor XIII deficiency has now joined my ever-expanding pantheon of new complications to worry about. ... The article entitled "Association of lethal acquired
Glucose monitors: Not as sweet as they seem
By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial
October 23, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 23, 2024 ... Botulinum toxin type A with topical minoxidil vs. topical minoxidil alone in males with androgenetic alopecia DermWorld Insights and Inquiries : Shocking news — Heat shock protein
Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8
Chronic Skin Conditions: Patient Reported Quality-of-Life ... DESCRIPTION: The percentage of patients aged 18 years and older with a chronic skin condition whose self-assessed quality-of-life was recorded at least once in the medical record within the measurement period. ... ... MEASURE ID: ... AAD8 ... ... Type:
Mentorship mentation: Bringing out the best of us!
By David A. Wetter, MD Sept. 9, 2020 Vol. 2, No. 36 I have been experiencing sports withdrawal during this COVID-19 life pause. I even (excitedly) gobbled up the recently televised NBA HORSE competition. Currently my family and I are enjoying ESPN’s 10-hour documentary ... The Last Dance , which
Interfering with interferon Gamma: The mechanisms behind acquired resistance to PD-1 inhibitors for melanoma
By Warren R. Heymann, MD Sept. 4, 2016 Astounding major advances in targeted therapies for melanoma, most notably by PD-1 blockade, have given hope and life to patients with metastatic melanoma. Approximately 30 % of advanced melanoma patients experience tumor responses from checkpoint blockade monotherapy, with better clinical responses seen
Vascular Ehlers-Danlos syndrome: From rupture to rapture?
By Warren R. Heymann, MD, FAAD February 16, 2022 Vol. 4, No. 7 If there was a statistic for a dermatological diagnostic impact factor, vascular Ehlers-Danlos syndrome (vEDS) would be at the top. Often undiagnosed until tragedy strikes, astute dermatologists who consider the diagnosis prior to an acute event may
June 1, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 1, 2022 ... What’s new in adult acne over the last two years? DermWorld Insights and Inquiries : Granulomatous cheilitis — Back to the Future Derm Coding Consult : Cigna’s
Compounding toolkit
Can you compound or prescribe it? ... Answer a few questions below to determine whether the type of compounding you are performing is in compliance with Food & Drug Administration (FDA) regulations and how to access the drug product if it cannot be compounded in your office. ... Are you
Key messages in social media about eczema
Key messages ... Eczema refers to a group of conditions that lead to inflamed skin. Signs of inflamed skin include a rash, itchiness, and excessive dryness. (1) ... There are several types of eczema. Atopic dermatitis is the most common type. ... Eczema is a complex condition. Your genes, immune
Learning module: Genetic skin diseases
Goals and objectives ... The purpose of this module is to help develop a clinical approach to the evaluation and initial management of patients presenting with genodermatoses. ... By completing this module, the learner will be able to: ... Identify and describe the morphology of skin lesions typical of tuberous
Addressing systems and administrative challenges
Running a successful dermatology practice hinges not only on exceptional patient care but also on efficient administration. While challenges vary based on practice type and other factors, most practices face common administrative burdens. These burdens are a major driver of burnout. ... Surveys conducted among Academy members between 2016-2020 revealed
New treatments provide more options for people with alopecia areata
Journal of the American Academy of Dermatology ... article highlights new ways to restore hair ROSEMONT, Ill. (Aug. 15, 2023) — A study published today in a supplement of the ... Journal of the American Academy of Dermatology titled " ... Alopecia: A New Frontier " reveals that a new
New study reveals that some children with common form of eczema should also be tested for allergic reactions
Study author highlights test used to differentiate between two types of eczema ROSEMONT, Ill. (September 26, 2023) — Eczema, which is a group of medical conditions that causes inflamed, irritated, and often itchy skin, affects millions of people worldwide. A new article published in the ... Journal of the American
Ustekinumab: A topic for atopics?
By Warren R. Heymann, MD Jan. 9, 2017 Atopic dermatitis patient shows drastic improvement at week 19 of ustekinumab treatment. ... Credit: ... JAAD If you’re like me, you have a cadre of patients with severe atopic dermatitis (AD) patients who are counting the minutes for the release of
Advocacy Update May 5, 2026
IN THIS ISSUE / May 5, 2026 Advocacy win: United Healthcare delays referral program penalties Dr. Gross attends political event on behalf of SkinPAC New Medicare physician payment reform legislative efforts AADA presents at FDA nonprescription drugs access public meeting Payer Advocacy Advocacy win: United Healthcare delays referral program penalties
Malpractice insurance 101
Experts offer advice on navigating malpractice insurance policies. ... Feature ... By Andrea Niermeier, Contributing Writer, February 1, 2025 While medical malpractice suits first regularly appeared in the United States in the 1800s, the frequency of claims has only increased since the 1960s, with lawsuits relatively common today. Medical malpractice
The doctor will see you...soon?
Facts at your Fingertips ... By Emily Margosian, assistant editor, July 1, 2019 As efforts to improve access to dermatologic care remain ongoing (Read ... Dermatology World ’s 2017 feature "Access Granted" at ... www.aad.org/dw/monthly/2017/october/access-granted for strategies to broaden patient access), how long can the average patient expect to wait
Focusing attention on X-linked ichthyosis
Ichthyosis vulgaris ... Credit: ... JAAD By Warren R. Heymann, MD Jan. 2, 2019 I thought it was me. Like every dermatologist, I learned the classical appearance of the ichthyoses, and wonder why I’m not sure if I am looking at a patient with ichthyosis vulgaris (IV) or X-linked ichthyosis
Dermatology antibiotic prescription trends
Facts at your fingertips ... By Emily Margosian, assistant editor, November 1, 2019 As antibiotic resistance has increasingly captured the attention of the media and global health organizations, physicians have found themselves under more pressure to monitor their antibiotic prescription habits. Although overall antibiotic prescribing by dermatologists decreased by 36.6%
Ransomware attacks on U.S. health care double
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, February 1, 2024 Ransomware is on the rise. A recent ... JAMA Health Forum study found that the annual number of ransomware attacks on health care organizations more than doubled from 2016 to 2021, exposing the personal health information (PHI)
Melanoma incidence rising, deaths decreasing
Facts at your fingertips ... By Emily Margosian, assistant editor, December 1, 2019 According to data from the National Institutes of Health (NIH) Surveillance, Epidemiology, and End Results Program (SEER), there were an estimated 96,480 new cases of melanoma of the skin in 2019 — making it the fifth most
Demand for cosmetic procedures resumes after COVID
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, April 1, 2023 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions due to the ebb and flow in national and regional caseloads. ... The release of new
Private payer appeal letter tool
How can I appeal insurance denials? ... Use the tool below to generate letters from automated templates. These letter templates are intended to help dermatologists appeal to private payers when payments are inappropriately reduced. They may be modified to specifically address your circumstances and those of your patients. ... {{
COVID’s impact on cosmetic procedures
Facts at your fingertips ... By Emily Margosian, Assistant Editor, April 1, 2022 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions throughout the year due to the ebb and flow in national and regional caseloads. The release
AAD membership at a glance
Facts at your Fingertips ... By Emily Margosian, content specialist, June 1, 2018 Which way are the winds of dermatology blowing? AAD membership data may serve as a bellwether. In 2018, overall membership surpassed 20,000 dermatologists, but beyond hitting the 20K mark, other demographic changes regarding gender and practice type
This month’s news from across the specialty
What’s hot ... August 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Maureen Offiah, MD, FAAD Several physician groups have recently modified the ... staging and classification of all primary cutaneous lymphomas (PCL). Changes to
Metformin mania: Is it an adequate chemopreventive agent for skin cancer?
By Warren R. Heymann, MD, FAAD Aug. 31, 2022 Vol. 4, No. 35 Precisely a century ago (in 1922) metformin was synthesized, based on the folk knowledge that the active, but toxic constituent guanidine galegine, (derived from French lilac, ... Galega officinalis ) could treat "sweet urine." Metformin is now
A dermatologic riddle: How is IgG4-related ophthalmic disease parliamentary?
By Warren R. Heymann, MD March 22, 2017 Immunostains of infiltrate. A, Immunostain shows an infiltrate rich in IgG4+ plasma cells. The infiltrate had an IgG4+ cell count of 80 per HPF and an IgG4+/IgG+ ratio of 80%. B, IgG immunostain shown for comparison. (A and B, original magnifications:
November 1, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 1, 2023 ... Can oral nutraceuticals reduce isotretinoin side effects? DermWorld Insights and Inquiries : Exchanging plasma exchange for a novel approach — The potential of FcRn antagonists in dermatologic
The nexus of VEXAS syndrome
By Warren R. Heymann, MD, FAAD December 1, 2021 Vol. 3, No. 47 You may not be familiar with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, but it is conceivable that you have already unknowingly encountered patients with the disorder. ... To appreciate the clinical nuances of the VEXAS
Checking in on the adverse reactions to checkpoint inhibitors
By Warren R. Heymann, MD Oct. 17, 2016 Earlier this year there have been two posts devoted to adverse reactions of checkpoint inhibitors ("Thinking of Discontinuing the PD-1 Inhibitor Because of a Lichenoid Eruption? Don’t do it!" published on May 21st and "Joining the Bullae Pulpit: PD-1 inhibitors" posted on
Alleviate the ouch
Experts share best practices and review the latest on safety concerns for anesthesia use in children. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2024 Use of anesthesia can be tricky in adults, but even trickier in children. The use of local or general anesthesia in pediatric dermatology
Waiting for Wong
By Warren R. Heymann, MD ... Oct. 6, 2016 ... The Wong variant of dermatomyositis was originally described by O’Leary during the Eisenhower administration (1953) and named for Wong during Nixon’s tenure (1969). I have been involved with dermatology since Carter’s term in office (1979). Since that time (Reagan,
What are keratoacanthomatous lesions of the legs in mature women?
By Warren R. Heymann, MD Dec. 11, 2017 ... Right thigh, keratoacanthomatous atypical squamous proliferation. (Hematoxylin-eosin stain; original magnification: ×10.) ... Credit: ... JAAD I have an increasing number of patients asking me questions about proliferating keratoacanthoma-like lesions on their shins. "Why am I getting these? Are they cancer? Why
Chanarin-Dorfman syndrome: Shifting out of neutral
By Warren R. Heymann, MD, FAAD Aug. 27, 2025 Vol. 7, No. 34 In nearly all neutrophil, eosinophil and basophil leukocytes and in the monocytes, several clear vacuoles of varying size were observed in the cytoplasm, which after vital staining…revealed a red colour, i.e. contained a fatty substance. The erythrocytes
Tressed to impress: tips for keeping your mane magnificent
6 tips for healthier looking and feeling hair from a board-certified dermatologist ROSEMONT, Ill. (Aug. 13, 2024) — Hair is as unique as its wearer, making care an important aspect in one’s overall health and wellness routine. From understanding your hair type to learning the best shampooing technique (yes, there
Reporting Quality for MIPS
The tracking of quality measures and the implementation of improvement activities can help to lead to improved outcomes in patient care and care processes. ... Quality measures ... AAD continues to expand the number and type of dermatology-specific measures for reporting to CMS. Access a complete list of MIPS measures
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy ... DESCRIPTION: If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy ... DESCRIPTION: If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month
March 1, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 1, 2023 ... Isotretinoin: Risk of IBS, ulcerative colitis, and Crohn’s disease? DermWorld Insights and Inquiries : Seeing red with dupilumab IL-17 inhibitors in psoriasis patients in the real world
Should benign cephalic histiocytosis be renamed? Let’s keep our heads about this decision.
By Warren R. Heymann, MD Sept. 4, 2017 Benign cephalic histiocytosis (BCH) is a rare non-Langerhans cell histiocytic disorder first recognized by Gianotti 46 years ago. (1) Over the years, I have seen several cases of both Langerhans cell histiocytosis (LCH), and non-Langerhans cell histiocytoses, but do not recall ever
The Term “Dermal Hyperneury” Hits a Nerve
By Warren R. Heymann, MD Dec. 21, 2017 ... A, On hematoxylin-eosin stain, the borders of this nerve bundle are sharply demarcated from the surrounding connective tissue with no associated inflammation or fibrosis. A thin layer of epithelium can be seen encapsulating the intersecting fascicles of nerve fibers. Within the
Tennessee legislation increases transparency
Tennessee Gov. Bill Lee (R) signed legislation limiting the use of medical specialty titles in advertisements. ... The new state law requires any advertisement for health care services to include the name of a health care practitioner and the type of licensure or profession held. The AADA believes that all
Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome
By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was
AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair
Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health
AAD Event Advertising: Annual Meeting
The Academy's Annual scientific meeting offers unprecedented access to thousands of dermatologists attending high-profile continuing medical education events. ... For exhibitors looking to promote their products and services, build booth traffic, and facilitate face-to-face discussions, the Academy offers a wide selection of high-impact advertising opportunities. Look here for advertising opportunities
2020 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... December 23 - 2020 holiday greeting December 16 - We’re in hot water! Vibrio vulnificus infections are heading north December 9 - Much ado about nothing in dermatopathology December 2 - Pigmented onychomatricoma: Avoid getting nailed by
Membership Committee portal
Welcome to the American Academy of Dermatology’s Membership Committee portal. The portal houses applications and their supporting documentation along with resources to help determine eligibility for membership. ... Applicant Name ... Type ... Category ... Country ... Status ... Review {{application.fullName}} ... {{application.pendingMemberType}} ... {{application.pendingMemberCategory}} ... {{application.businessAddressCountry}} ... {{application.status}} ...
Transplantation dermatology: Race matters
By Warren R. Heymann, MD June 21, 2017 African American man with generalized vitiligo. Medial aspect of foot before (A) and 5 months after (B) melanocyte-keratinocyte transplantation procedure. ... Credit: ... JAAD December 3rd, 2017 will mark the 50th anniversary of the first human-to-human heart transplant performed by the late
Knuckling down on knuckle pads
By Warren R. Heymann, MD April 1, 2020 Vol. 2, No. 13 Today is April Fools’ Day. Thus far, 2020 has felt like April Fools’ Year. All of us are dealing with COVID-19, 24/7. During World War II, morale was lifted by the song "There’ll be bluebirds over the White
Atrophic tinea versicolor: Knowledge about its pathogenesis is hypertrophying
By Warren R. Heymann, MD April 12, 2017 In the entry "Atrophic Tinea Versicolor: More Than a Mirage" (April 22, 2016), I learned that the atrophic appearance of some cases of tinea versicolor is not just an optical illusion. The case of a 35-year-old man with depressed brown lesions on
Key messages to communicate about Indoor tanning
Key messages ... Using indoor tanning beds can increase your risk of skin cancer, including melanoma, the deadliest form of skin cancer. (1-15) ... Using tanning beds before age 20 can increase your chances of developing melanoma by 47%, and the risk increases with each use. (16) ... Women younger
What's hot?
What's hot ... February 26, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Isn’t it interesting how some common warts that we treat seem to go away almost instantly but others persist
March
Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... I always knew firefighting was a dangerous occupation What’s hot ... This month’s news from across the specialty Clinical Applications ... Do skin cancer
The retiring type?
By Warren R. Heymann, MD April 23, 2017 "Tell me, Dr. Heymann, when do you plan to retire?" ... Patients seem to ask me that every day. ... My usual response: "Why do you ask, do I look that bad?" ... "No, you look pretty good for your age." (According
Studying skin aging never gets old: The potential role of oxytocin
By Warren R. Heymann, MD Oct. 14, 2020 Vol. 2, No. 41 Every day, dermatologists address patient concerns about their aging skin — whether they are presenting for medical, surgical, or cosmetic problems. Extrinsic factors such as ultraviolet light and smoking resulting in a leathery, coarsely wrinkled appearance are well
My fair-weather therapeutic friends for alopecia areata
By Warren R. Heymann, MD April 25, 2017 Type C clinical pattern of alopecia. A, Patchy hair loss on a background of a diffuse hair loss with (B) occipital involvement in an ophiasis-like pattern. C, Biopsy specimen obtained from the vertex of the scalp. Histopathology of vertical sections shows an
Mohs Surgery Appropriate Use Criteria (AUC) app
There are many considerations when determining whether to use Mohs surgery for the treatment of skin cancer, such as the cancer type, location, and whether it is new or recurring, as well as the health profile of the patient. ... With the Academy's complimentary Mohs Surgery Appropriate Use Criteria (AUC)
Platelet rich plasma: Good for whatever ails you?
By Warren R. Heymann, MD Jan. 13, 2017 Hair regrowth in ophiasis-type alopecia areata after platelet-rich plasma (PRP) injection. Occipital hair loss before treatment (A) and occipital hair regrowth 3 months after administration of PRP at a concentration 3.5 times above baseline (B). ... Credit: ... JAAD Okay, okay, I
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon
By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive
November 18, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / November 18, 2020 ... Hydrogen peroxide and the common wart: Phase 2 results are in DermWorld Insights and Inquiries : Granulomatous slack skin — More than one type of mimicry FDA
January 30
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / January 30, 2019 ... Dermatologists prescribe fewer antibiotics overall, but use increased with surgery CMS updates Open Payments data What causes allergic responses in patients with atopic dermatitis? YouTube videos about
Intermediate and complex repairs 2020: Part 1
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, October 1, 2019 Test your knowledge: Intermediate and complex repairs 2020 — Part 1 ... Take the quiz to
Practice types in dermatology
Dermatologists can choose from a diversity of practice types, from independent to group and institutional. Each of these practice types comes with trade-offs between between autonomy and support, benefits and risks. There are also new practice models, meant to improve value and contain costs. Use the AAD resources below to
Contract reimbursement review
When deciding whether to sign a contract with a payer, reimbursement is one of the most important considerations. Adequate reimbursement is critical to the viability of your practice. Therefore, be sure to review contract language on reimbursement carefully. ... Aspects of reimbursement are often negotiable, though the extent to which
Advocacy Update Feb 3, 2026
IN THIS ISSUE / Feb. 3, 2026 Dermatologists urged Washington state to support truth in advertising Humana corrects destruction code denials Academy asks CMS to reduce regulatory burdens on dermatology Contribute to SkinPAC Truth in Advertising Dermatologists urged Washington state to support truth in advertising ... The AADA ... urged
4 cradle cap tips from dermatologists
Tips from board-certified dermatologists ROSEMONT, Ill. (August 18, 2022) — Bringing home a new baby is a joyous time for any parent. For first time parents, bringing home a new baby can unlock a wide range of emotions—from excitement to nervousness. As you adjust to parenthood, you’ll notice that your
New data to recall when considering radiation recall dermatitis
By Warren R. Heymann, MD Sept. 30, 2020 Vol. 2, No. 39 I have always been mystified by the diagnosis of radiation recall dermatitis (RRD). RRD was first described in 1959 by D’Angio et al who stated: "Actinomycin D therapy alone can reactivate ‘latent’ radiation effects in normal tissues. For
AAD's guidance on resources related to workplace violence
Unfortunately, violence in the workplace has become more common in health care and incidences are slowly rising. Has someone at your dermatology practice ever experienced any type of violence at work? Is your practice equipped or prepared to handle violence, if it were to occur? Dermatologists are not always trained
How to prevent keloid scars
Board-certified dermatologist shares tips to reduce your risk ROSEMONT, Ill. (Dec. 6, 2023) — Keloids are a type of raised scar that can occur after an injury, and over time they can grow much larger than the wound itself. Although keloids are not dangerous to a person’s health, they can
July 1, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 1, 2020 ... Derm Coding Consult : E/M coding — What has changed? DW Insights and Inquiries : Spironolactone — An increasingly recognized hero in acne therapy Is it ethical
Are teens tanning less?
Go to AAD Home ... Go to AAD Home ... Menu ... Signs point to progress, but work remains ... Signs point to progress, but work remains ... By Ruth Carol, contributing writer It appears that fewer teens are indoor tanning in recent years, but the data are sparse. Regulations
Seeing red with dupilumab
By Warren R. Heymann, MD, FAAD March 1, 2023 Vol. 5, No. 9 Since its release in 2017, dupilumab (a fully humanized monoclonal antibody that blocks IL-4 and IL-13) has transformed the therapeutic landscape for managing atopic dermatitis (AD) and other eczematous disorders, bullous pemphigoid, Kimura disease, etc. when used
RAC audits: Target areas
This page has quick tips, facts, and links for you to keep on hand so that you can stay on top of the audit game. ... Where a RAC will catch you ... It goes without saying that you must be careful about many procedures when you’re a physician. However,
Giving a NOD2 to Yao syndrome
By Warren R. Heymann, MD, FAAD March 5, 2025 Vol. 7, No. 9 The 21 ... st ... century has witnessed an expanding array of systemic autoinflammatory disorders (SAIDs) due to innate immunity dysfunction. SAIDs are characterized by recurrent attacks of fever, cutaneous signs, chest or abdominal pain, lymphadenopathy, vasculopathy,
Write this down if your patient has multiple PENS: Look further
By Warren R. Heymann, MD June 18, 2016 Papular Epidermal Nevus with Skyline Basal Cell Layer (PENS) was first described by Torrelo et al. They detailed 5 infants with solitary or multiple 1 to 7 mm congenital keratotic papules. Lesions were randomly distributed and did not follow Blaschko lines. They
Advocacy Update Feb. 4 2025
IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC
CMS Targeted Probe and Educate (TPE) reviews are now in full swing
What is a Targeted Probe and Educate program? ... A Targeted Probe and Educate (TPE) program is a claim review process utilized by the Medicare Administrative Contractor (MACs) designed to help dermatologists reduce claim and billing denials as well as appeals through "one-on-one" corrective action assistance and is overseen by
Pregnant with possibility: Rituximab prophylaxis for pemphigoid gestationis
By Warren R. Heymann, MD April 26, 2018 ... Pemphigoid gestationis in 34-year-old primigravida at 28 weeks gestation. A, Urticated erythema with multiple tense blisters on both thighs. B, Histopathologic findings reveal subepidermal blister formation with abundant eosinophils, accompanied by superficial and middermal perivascular lymphohistiocytic infiltrate. (Hematoxylin-eosin stain; original magnification:
Dermatology resident develops face masks from recycled medical supplies
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... DermWorld Weekly talks with Aditi Sharma, MD, a third-year resident in the department of dermatology at the University of California, Irvine, about how she produced a new type of protective face mask made from recycled
Advocacy Update Dec 9, 2025
IN THIS ISSUE / Dec. 9, 2025 AADA endorses annual inflationary update to Medicare payment legislation Upcoming formulary prior authorization changes to Blue Cross Blue Shield’s federal employee coverage Podcast highlights advocacy on dermatopathology payer and regulatory challenges AMA offering $1 million in community health program grants Peter Friedman, MD,
Taking the challenge: Social media, adolescents, and the skin
By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the
Unrestricted fascination with restrictive dermopathy
By Warren R. Heymann, MD, FAAD Nov. 16, 2022 Vol. 4, No. 46 Barely a week into our fellowships at the University of Pennsylvania in 1984, my wife (a geneticist) asked her favorite dermatologist (me) if I had any thoughts about a neonate with skin that was thin, taut, and
September 1, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 1, 2021 ... Which dermatology patients should receive a third dose of mRNA vaccine? DermWorld Insights and Inquiries: Shedding light on the hydroa vacciniforme-like lymphoproliferative disorder Obesity, diabetes associated with
December 1, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 1, 2021 ... Risk of COVID-19 infection in atopic dermatitis patients DermWorld Insights and Inquiries : The nexus of VEXAS syndrome Skin and gut microbiome in hidradenitis suppurativa Is imiquimod
October 1, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 1, 2025 ... Antiandrogen therapy for the treatment of female pattern hair loss DermWorld Insights and Inquiries : Lupus miliaris disseminatus faciei — A Simon and Garfunkel playlist Academy mourns
Treatments for renal IgA vasculitis are beginning to flow
By Warren R. Heymann, MD, FAAD Feb. 19, 2025 Vol. 7, No. 7 The alliterative phrase "palpable purpura" will instantly conjure the diagnosis of leukocytoclastic vasculitis (LCV) for dermatologists. IgA vasculitis (IgAV, aka Henoch-Schönlein purpura [HSP]) is the most common vasculitis in children but is much less frequent in adults.
Applying the 2021 E/M coding concepts in everyday practice – Part 1
The introduction of the revised 2021 evaluation and management (E/M) coding guidelines has generated a plethora of questions from dermatologists in the application of the concepts used in the ... medical-decision making table (MDM). ... To help members navigate the E/M changes in a simplified and relatable manner in everyday
CBD: Potential or placebo?
Go to AAD Home ... Go to AAD Home ... Menu ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... By Emily Margosian, assistant editor This recent Mother’s Day holiday, shoppers may have observed
Academy physician leaders meet with federal legislators
On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...
Evaluation and management in 2021: Part 1
Cracking the code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, September 1, 2020 Test your knowledge: Evaluation and management in 2021: Part 1 ... Take the quiz to see
Optimizing financial efficiency: Part 1
Experts offer advice on best practices to ensure financial health before the appointment begins. ... Feature ... By Megan Bennett, Staff Writer, May 1, 2026 When opening her private practice in 2022, Suzanne McGoey, MD, MPH, FAAD, also discovered the challenges of managing the business of medicine. ... "We do
Paraneoplastic syndromes (PNS) associated with merkel cell carcinoma are analogous to small cell cung Cancer: A comparison to other lung cancers
By Warren R. Heymann, MD Sept. 2, 2016 Merkel cell carcinomas (MCC) are neuroendocrine tumors associated with the Merkel cell carcinoma polyomavirus in >80% of tumors (1). Small cell lung cancer, another neuroendocrine tumor, is associated with paraneoplastic syndromes (PNS) in up to 20% of cases, notably the syndrome of
April 1, 2026
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 1, 2026 ... Aesthetic treatment considerations for perimenopausal, menopausal patients DermWorld Insights and Inquiries : Cocaine-associated plasma cell orificial mucositis — Anything goes Effects of PRP, minoxidil in patients with
Leaders in medicine – Part 1
DermWorld talks to dermatologists in leadership roles in the house of medicine. ... Feature ... By Matthew Walsh, Member Communications Specialist, May 1, 2023 The American Academy of Dermatology is one of hundreds of medical associations in the U.S., each offering opportunities for doctors to assume important leadership positions. Engaged
Spironolactone: An increasingly recognized hero in acne therapy
By David A. Wetter, MD July 1, 2020 Vol. 2, No. 26 In 1983, Bonnie Tyler released the catchy and powerful anthem, "Holding Out for a Hero." Emotion exudes from the lyrics: ... I need a hero I’m holding out for a hero ‘til the morning light He’s gotta be
May 1, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 1, 2024 ... Consensus statements for the treatment of vitiligo in younger patients DermWorld Insights and Inquiries : Eyebrow-raising complications of microblading Role of low-dose oral minoxidil for treatment of
February 1, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 1, 2023 ... Are topical AK treatments associated with increased risk of SCC? DermWorld Insights and Inquiries : A seasoned approach to treating the ‘salt and pepper’ dyspigmentation of systemic
I don’t know JAK — but I will! Ruxolitinib improving chilblain lupus erythematosus
By Warren R. Heymann, MD May 31, 2016 The JAK inhibitors are among the current darlings of treating autoimmune diseases. Recent articles about tofacitinib for vitiligo (1) and alopecia areata (2) have been reported in the lay press with considerable fanfare. ... Ruxolitinib (Jakafi) is indicated for treating intermediate to
JAAD wins again!
JAAD has retained the #1 position as the most impactful journal in dermatology according to the 2024 Clarivate Journal Impact Factor (JIF). ... JAAD is No. 1 in the field of dermatology for the sixth year in a row, with a JIF of 11.8 and 38,702 total citations. ... But
April 1, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 1, 2020 ... What to do with iPLEDGE patients during COVID-19 DW Insights and Inquiries : Knuckling down on knuckle pads Medicare offers physicians advance payments to address COVID-19 cash-flow
JAAD ranks no. 1 among dermatology journals
The Journal of the American Academy of Dermatology’s impact factor remains #1 in field ROSEMONT, Ill. (July 2, 2024) — The ... Journal of the American Academy of Dermatology remains the top peer-reviewed journal in its field, according to the 2023 journal impact factor rankings recently published by Clarivate’s Journal
JAAD ranks no. 1 among dermatology journals
The Journal of the American Academy of Dermatology’s impact factor remains #1 in field ROSEMONT, Ill. (July 5, 2023) — The ... Journal of the American Academy of Dermatology remains the top peer-reviewed journal in its field, according to the 2022 journal impact factor rankings recently published by Clarivate’s Journal
Dermatology coding essentials part 1: Pearls, pitfalls, and best practices
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding & Reimbursement, April 1, 2026 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . Your ability to deliver excellent patient care
Appropriate Documentation and Shared Decision Making of AK — QCDR measure AAD 21
Actinic Keratosis: Appropriate Documentation and Shared Decision Making of AK ... DESCRIPTION: Percentage of adult patients (18 years old and older) diagnosed with Actinic Keratosis (AK) whose healthcare provider has recorded the following information in the patient’s medical record 1) documentation of the number or range of AKs, 2) location(s)
Psoriasiform eruptions during Kawasaki disease (KD): A prognosis that lets the good times roll
By Warren R. Heymann, MD June 27, 2016 Psoriasiform skin changes have been rarely described in the literature in both acute (1-4 weeks) and convalescent phases (4-12 weeks) of KD (1). ... Haddock et al, in their review of 870 cases of KD, identified 11 patients with a psoriasiform eruption
Shedding light on the hydroa vacciniforme-like lymphoproliferative disorder
By Warren R. Heymann, MD, FAAD Sept. 1, 2021 Vol. 3, No. 35 Hydroa vacciniforme (HV) has always mystified me in every respect — its clinical presentation, pathophysiology, prognosis, and even its name. I understand "vacciniforme" because residual scars may resemble those of smallpox. I was surprised to learn that
Surviving and thriving after a natural disaster
Answers in Practice ... By Emily Margosian, Assistant Editor, September 1, 2023 DermWorld ... talks to Mary Lupo, MD, FAAD, from the Lupo Center for Aesthetic and General Dermatology in New Orleans, about how to prepare your practice for a natural disaster. Mary Lupo, MD, FAAD ... DermWorld: Tell us
Granulomatous slack skin: More than one type of mimicry
By Warren R. Heymann, MD November 18, 2020 Vol. 2, No. 46 My chief resident presented a case to me enamored with his clinical diagnosis of granulomatous slack skin (GSS). Although I was delighted that he considered the disorder, I explained why I thought these inguinal and submammary pink-white subtly
Biopsy coding in 2019: Part 1
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, November 1, 2018 Dermatologists commonly biopsy skin lesions via a tangential shave technique, with a punch, or with a
The journey of focal dermal hypoplasia: From description to inspired therapy
By Warren R. Heymann, MD Oct. 9, 2017 The dermatologic community lost a giant in 2014 with the passing of Robert W. Goltz, MD at the age of 90. Dr. Goltz was not only responsible for describing focal dermal hypoplasia (FDH), but also multicentric reticulohistiocytosis, generalized elastolysis, and the nevoid
Sweating over sweat gland carcinomas: Part 2 — Eccrine mucin-producing sweat gland carcinoma
By Warren R. Heymann, MD, FAAD Aug. 20, 2025 Vol. 7, No. 33 As I write this commentary, March Madness is underway. According to the NCAA, the odds of predicting all 63 NCAA tournament games correctly are approximately 1 in 9.2 quintillion (a quintillion is 10 to the 18th power).
Excludes notes
ICD-10 Excludes notes: In a nutshell ... ICD-10-CM codes include two sets of exclusions. ... Excludes 1 exclusions indicate when two codes cannot be billed at the same time. ... Excludes 2 exclusions indicate that the codes are separately billable. ... Excludes 1 Note ... Within the ICD-10-CM manual, you
Playing the field: Introducing tirbanibulin for actinic keratosis therapy
By Warren R. Heymann, MD January 27, 2021 Vol. 3, No. 4 Field therapy is a cornerstone of actinic keratosis (AK) management. Two years ago, a ... New England Journal of Medicine article demonstrated that 5-fluorouracil (5-FU) was the best among inadequate therapies (compared to imiquimod, MAL-PDT, and ingenol mebutate).
February 16, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 16, 2022 ... A review of calcipotriol plus 5-fluorouracil for actinic keratosis DermWorld Insights and Inquiries : Vascular Ehlers-Danlos syndrome: From rupture to rapture? Delayed complications for FDA-approved HA dermal
Striving for hard facts about water softening in atopic dermatitis
By Warren R. Heymann, MD, FAAD Aug. 18, 2021 Vol. 3, No. 33 With the success of dupilumab in managing atopic dermatitis (AD), and new agents on the horizon (IL-13 inhibitors lebrikizumab and tralokinumab; the IL-31 inhibitor nemolizumab; targeted anti IL-17, IL-22, and TSLP inhibitors; JAK inhibitors; and the PDE4
Eosinophilic pustular folliculitis: Six decades of progress
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, March 1, 2026 Vol. 8, No. 3 Eosinophilic pustular folliculitis (EPF) is a quizzical disorder. In 1965, Ise and Ofuji described the case of a 42-year-old woman who "repeatedly developed crops of small pustules on the face, the trunk,
Advocacy Update Jul 1, 2025
IN THIS ISSUE / July 1, 2025 Senate advances reconciliation bill with 2026 Medicare Physician Payment increase RFK pledges to work with Rep. Joyce on Medicare physician reimbursement CMS suspends CLIA lab director restrictions AADA and DermCAC support inclusion of dermatologists in SRT Local Coverage Determinations Build a relationship with
Granulomatous cheilitis: Back to the Future
By Warren R. Heymann, MD, FAAD June 1, 2022 Vol. 4, No. 22 I opened my dermatology practice in 1985 — looking retrospectively, life was then both simpler and more complicated. It was the pre-computer era when patients paid their fee at the time of their visit, utilizing a peg-board
Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections
By Warren R. Heymann, MD Aug. 21, 2019 Vol. 1, No. 24 Dermatologists are keenly aware of immunosuppression’s profound biologic effects. Whether by disease or iatrogenic means, clinical vigilance is mandated because of an elevated risk of malignancy, infection, or inflammatory dermatoses. ... In a study of 177 organ transplant
Nonepidemic Kaposi sarcoma: The fifth dimension
By Warren R. Heymann, MD Oct. 16, 2019 Vol. 1, No. 32 ... For more than a century, since first described in 1872 by Moritz Kaposi* as "idiopathic multiple pigmented sarcoma," dermatologists focused on classical Kaposi sarcoma (KS) — violaceous patches, plaques, and tumors on the lower extremities of
Advocacy Update Apr. 1, 2025
IN THIS ISSUE / Apr. 1, 2025 HHS announced major department restructuring Senate confirms Drs. Bhattacharya to lead NIH and Makary to head FDA Step therapy reform bill headed to New Jersey governor Contribute to SkinPAC Regulatory Affairs HHS announced major department restructuring ... On March 27, the Department of
We are your No. 1 high impact journal
For the fourth straight year, the Journal of the American Academy of Dermatology (JAAD) ranked as the top peer-reviewed journal in its field, according to journal impact factor rankings published by Clarivate’s Journal Citation Reports (JCR) Web of Science Group. With an impact factor of 13.8, JAAD is in the
Telehealth policy changes take effect; shutdown impacts Medicare claims processing
In the ... Medicare Learning Network (MLN) Update on Medicare Operations: Telehealth, Claims Processing, and Medicare Administrative Contractors Status During the Shutdown of Oct. 1, 2025, CMS announced that significant changes to Medicare telehealth services that took effect on Oct. 1, 2025, may impact the processing of Medicare telehealth claims.
Hair restoration taking root among young people, women
Facts at your Fingertips ... By Megan Bennett, Staff Writer, January 1, 2026 Interest in hair restoration is growing, with women and young adults seeking hair loss surgery at higher rates, according to a member survey from the ... International Society of Hair Restoration Surgery . ... ISHRS — which
Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease
By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with
It’s JAAD, again, of course!
For the ... fifth year in a row, ... JAAD has retained its position as the #1 most impactful journal out of 94 dermatology journals measured in Clarivate’s 2023 Journal Citations Report (JCR) Web of Science. ... Here are the details: ... JAAD ’s impact factor is 12.8 ... JAAD
Thinking of discontinuing the PD-1 inhibitor because of a lichenoid eruption? Don’t do it!
By Warren R. Heymann, MD May 21, 2016 Immune checkpoint inhibitors have been the proverbial "game changers" in oncology, and offer hope (and a chance of survival) where none existed just a few years ago. ... Cutaneous manifestations are the most common adverse reactions to these drugs. Indeed, more than
A seasoned approach to treating the “salt and pepper” dyspigmentation of systemic sclerosis
By Warren R. Heymann, MD, FAAD Feb. 1, 2023 Vol. 5, No. 5 It only takes a nanosecond for a dermatologist to recognize the "salt and pepper" dyspigmentation (SPD) of systemic sclerosis (SSc), but a lifetime to understand and manage it. Of all the cutaneous signs of SSc (sclerodactyly, telangiectasias,
What you read in 2024: AAD publications roundup
JAAD still making an impact For the ... fifth year in a row, ... JAAD retained its position as the #1 most impactful journal out of 94 dermatology journals measured in Clarivate’s 2023 Journal Citations Report (JCR) Web of Science. ... Here are the details: ... JAAD ’s impact factor
Claim Reopenings or Level 1 Appeals for Denied Services
Not every Medicare denial requires a formal appeal. Most Medicare Administrative Contractors (MAC) have developed automated claim "reopenings" to handle these simple corrections. This method significantly reduces the amount of time required to reprocess a denial. It is important that reopenings be submitted on the correct form, which can be
This month’s news from across the specialty
What’s hot ... February 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MS, MPH, FAAD ChatGPT is a readily accessible and widely available artificial intelligence tool mainly used by physicians for administrative
Applying the 2021 E/M coding concepts in everyday practice – Part 3
Part three of the AADA’s clinical vignettes focuses on the application of the more challenging concepts related to the review and analysis of data in the AMA Medical Decision-Making table. Understanding the application of these concepts will assist you in determining when data may impact the level of service provided.
Not just for boys: X-linked erythropoietic protoporphyria
By Warren R. Heymann, MD Sept. 7, 2017 I was anxiously awaiting the results of erythrocyte protoporphyrin levels obtained from a 4 year-old boy who avoids sunlight because his "skin hurts" when not in the shade. Until I read the article by Balwani, et al (1), I was unaware of
This month’s news from across the specialty
What’s hot ... March 1, 2026 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Harry Dao Jr., MD, FAAD Injectable biologics remain the gold standard for achieving optimal clinical responses in psoriasis, but fear of injections leads many
This month's news from across the specialty
What's hot ... July 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD The FDA has approved the first treatment for progeria (Hutchinson-Gilford progeria syndrome). As we all know, progeria is a rare
COVID-19 impact on employed dermatologists: Part 1
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, D.C. ... By Ben Tesdahl, JD, Megan La Suer, JD, MHA, and Rob Portman, JD, MPP, September 1, 2020 Every month, Dermatology World ... covers legal issues in "Legally
Biotin supplementation for hair and nail health: Does it pass the test?
By Warren R. Heymann, MD, FAAD November 17, 2021 Vol. 3, No. 46 When patients ask me about biotin supplementation for their hair or nails, the usual question is what dose they should take, not whether or not it has any value. High dose over-the-counter biotin supplements (≥ 5 mg/day,
1 million patients affected by ransomware in one month
Facts at your fingertips ... By Emily Margosian, Assistant Editor, July 1, 2022 Ransomware attacks seeking valuable patient records thus far show no signs of slowing down in 2022. In March 2022 alone, 26 health organizations reported to HHS that they had been affected by data breaches, impacting nearly one
Changing a long-standing habit
By Warren R. Heymann, MD April 16, 2016 Topical corticosteroid has no influence has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratosis (AK): A randomized clinical trial. ... This is a randomized controlled clinical trial of patients with multiple AK and
Vitiligo or vitiligo-like lesions and PD1-inhibitors: Which is right?
By Warren R. Heymann, MD June 1, 2017 The following is a well-known staple of Jewish humor. I’ve heard it thousands of times, but it always makes me smile: ... In a small town in Russia, people brought their complaints to the Rabbi to settle their differences. One man purchased
Treating acrodermatitis continua of hallopeau in 2018? Try guselkumab!
By Warren R. Heymann, MD April 21, 2017 Acrodermatitis continua of Hallopeau (ACH) is a disorder well known to dermatologists, but absolutely mysterious to everyone else. It is now considered a localized form of pustular psoriasis of the digits that may be accompanied by onychodystrophy and osteolysis. ... In my
What's hot?
What's hot ... July 24, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... The first human retrovirus, identified in 1980, was not HIV, but human T-cell lymphotrophic virus-1 (HTLV-1). It
This month’s news from across the specialty
What’s hot ... June 1, 2022 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD A recent study compared lipidomes and transcriptomes of single cell dermal fibroblasts to explore the determinants of cell
Shedding light on treatments for female pattern hair loss
Dermatologist hair experts discuss the efficacy and safety considerations of off-label treatments for female pattern hair loss. ... Feature ... By Allison Evans, Assistant Managing Editor, April 1, 2025 A female patient presents with thinning hair and a reduction in hair density at the top of the scalp. Is it
Avoid the opioid
Experts offer advice on effective pain management in dermatology. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2026 Many dermatoses and dermatologic procedures are painful, but consensus on pain management in dermatology is limited, and complicated not only by the individual and varied experience of pain, but also
Why you should hear about the red ear syndrome
By Warren R. Heymann, MD July 22, 2020 Vol. 2, No. 29 Is it my imagination that the "by the way" comments at the presumed end of a patient encounter cause the most angst? Usually, it’s something like "Oh, I forgot to mention that I’m losing my hair!" Recently, at
Coming clean on bleach baths for atopic dermatitis
By Warren R. Heymann, MD Oct. 23, 2019 Vol. 1, No. 33 ... Bleach baths have become popularized over the past decade in managing atopic dermatitis (AD). I have been a strong proponent, often telling patients (and their parents) that the procedure would help decolonize the skin and prevent
What’s up in Down syndrome?
By Warren R. Heymann, MD, FAAD October 13, 2021 Vol. 3, No. 41 Being married to a geneticist has served me well as a dermatologist. Just as dermatologists can instantly diagnose many dermatoses based on pattern recognition, geneticists skilled in dysmorphology can identify many syndromes in a heartbeat. Physicians of
The role of GLP-1s in dermatology
Dermatologists discuss how the use of GLP-1s has offered potential new avenues for patients with chronic inflammatory skin diseases. ... Feature ... By Allison Evans, Assistant Managing Editor, January 1, 2026 Over the past five years, the approvals of glucagon-like peptide-1 receptor agonists (GLP-1s), particularly semaglutide and tirzepatide, have sparked
Educating the public — National Healthy Skin Month
30 healthy skin days hath November! ... November was National Healthy Skin Month and the AAD was Johnny on the Spot (whatever that spot may be) on Nov. 1 ... with information across aad.org and our @AADskin social media channels educating the public on healthy skin from head to toe
Keeping abreast of the expanding literature of implant-associated Anaplastic Large Cell Lymphoma (ALCL)
By Warren R. Heymann, MD July 6, 2016 Silicone gel implants were removed from the US market in 1992 because of health concerns, only to be reintroduced in 2006, with the provision for increased surveillance of health outcomes (1). I was under the (apparently mistaken) impression that the FDA put
AAD settled into Seattle for Innovation Academy
The AAD held its latest Innovation Academy meeting Aug. 1-4 in Seattle. Attendees heard from innovators, visionaries, entrepreneurs, and problem solvers who are changing the practice of dermatology, or medicine in general. ... In addition to many informative sessions and events, Innovation Academy featured a talk by famed swimmer Diana
Advocacy Update Jan. 21 2025
IN THIS ISSUE / Jan. 21, 2025 MedPAC recommends 2026 Medicare payment update linked to inflation Advocacy win: FTC releases second report on egregious PBM practices AADA urges UnitedHealthcare to rescind laser policy for vitiligo Dr. Green hosts Rep. Elfreth to discuss Medicare physician payment reform SkinPAC hosts breakfast for
LIDA* rose the insulin requirement
By Warren R. Heymann, MD April 14, 2021 Vol. 3, No. 15 * Localized insulin-derived amyloidosis ... Amyloidosis, I thought I knew ye. But alas, you fooled me again. ... Amyloid is an insoluble protein folded in ... β -pleated sheets that is deposited extracellularly. Amyloid can accumulate in one
Fighting detrimental Medicare payment cuts
As our top federal legislative priority, your Academy fought all year against Medicare payment cuts of 8.5% or more that were scheduled to begin on Jan. 1, 2023. ... As a result, in late December, President Biden signed into law an omnibus spending package that included partial relief from the
Sweating over sweat gland carcinomas: Part 1 — Squamoid eccrine ductal carcinoma
By Warren R. Heymann, MD, FAAD Aug. 13, 2025 Vol. 7, No. 32 A highlight of my week is leisurely reading the ... Philadelphia Inquirer on quiet Sunday mornings, skimming over the troubling headlines, and concentrating on positive happenings in the Delaware Valley. My bliss was rudely interrupted by a
Evaluation and Management (E/M) coding changes are coming in 2021 – Part 1
Several major E/M guideline revisions will go into effect Jan. 1, 2021, including: ... E/M guideline additions, revisions, and restructuring; ... Deletion of CPT code 99201 and revision of CPT codes 99202 – 99215 ... Updates to components for code selection to include: ... A medically appropriate history and/or physical
Teatime for radiation dermatitis (and beyond)
By Warren R. Heymann, MD, FAAD June 14, 2023 Vol. 5, No. 24 I am biased — as a coffee lover, I only believe articles demonstrating coffee’s benefits, while finding flaws in any study deriding its use. I can be more objective about tea — especially green tea — a
Pityriasis rubra pilaris: Check a TSH!
By Warren R. Heymann, MD ... June 10, 2016 ... There are myriad ways to mine the data from the review of 100 cases of PRP by Ross et al, however, one key finding will change the way I will assess these patients — 20% were hypothyroid! (1) ... There
The rosy reality of coffee
Ronnie and me enjoying our rosacea prevention tour of Madrid in 2012 ... By Warren R. Heymann, MD Nov. 5, 2018 To paraphrase Justice Kavanaugh, I loved coffee. I still love coffee. I have probably been drinking coffee since my time in utero. My mother was a coffee addict; she
CMS creates permanent drug code for treating molluscum contagiosum
Last updated: March 5, 2026 ... CMS has created a permanent drug code, J7354, for cantharidin, a drug used to treat molluscum contagiosum in adult and pediatric patients 2 years and older. The new J-code became effective on April 1, 2024. ... Cantharidin is the first ... FDA-approved topical treatment
Talk of the town: JAK inhibitors in dermatology
Dermatologists discuss the influx of new JAK inhibitors in dermatology and how they are breaking new ground for the specialty. ... Feature ... By Allison Evans, Assistant Managing Editor, April 1, 2024 Over the last decade, research and development of Janus kinase (JAK) inhibitors have exploded. Three years ago, JAK
CMS Releases 2020 First Quarterly NCCI PTP Edits
The Centers for Medicare & Medicaid Services (CMS) has released the first Quarterly Update to the National Correct Coding Initiative (NCCI) Procedure-to-Procedure (PTP) Edits, Version 26.0, which will go into effect on January 1, 2020. ... As part of the effort to promote correct coding and to minimize inappropriate payments
Tofacitinib: A JAK inhibitor of all trades
By Warren R. Heymann, MD April 3, 2019 Vol. 1, No. 4 The Janus kinase inhibitors are taking the dermatologic therapeutic world by storm — at least in the literature. By now, most dermatologists are familiar with studies that have demonstrated efficacy in alopecia areata, vitiligo, psoriasis, psoriatic arthritis, and
Injecting ideas (and therapies) in digital mucous cysts
By Warren R. Heymann, MD, FAAD Oct. 8, 2025 Vol. 7, No. 40 I am almost embarrassed to admit it, but I go on clinical autopilot when it comes to digital mucous (myxoid) cysts (DMCs). I offer a brief explanation, reassure the patient that the lesion is benign, refer the
Tackling Stevens-Johnson syndrome/toxic epidermal necrolysis: Part 1
Diagnosis and common mimickers. ... Feature ... By Emily Margosian, Senior Editor, May 1, 2026 Among serious diseases treated by dermatologists, Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) often top the list. ... Rare disorders of the skin and mucous membranes, SJS and TEN are thought to be clinically
Postmortem: AADA Legislative Conference
From the President ... Dr. Tomecki served as Academy president from March 2021 to March 2022. ... By Kenneth Tomecki, MD, FAAD, November 1, 2021 Postmortem : "examination of a dead body," or "process of evaluating success (or failure) of a project’s ability to meet its goals." Given that definition,
This month’s news from across the specialty
What’s hot ... September 1, 2025 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Harry Dao Jr., MD, FAAD News flash: As of June 20, 2025, ... dupilumab is officially FDA-approved as the first targeted treatment for
Advocating on behalf of dermatology is an enduring obligation
From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, December 1, 2019 The year is winding down, and as usual I find myself reminiscing about the last 12 months — thinking about all of the patients I
Happy November!
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, FAAD, November 1, 2021 When I write my column each month, I try to highlight the most interesting themes. I was struck this month by the diversity of the topics we covered,
I never wanted chaperones — until now
By Warren R. Heymann, MD Sept. 25, 2019 Vol. 1, No. 29 My oldest brother George had just gotten his driver’s license — under no circumstances would my mother allow him to drive his date Ruth to the movies. George protested vehemently, but ultimately relented, with my mother sitting in
Lipoid proteinosis’ weak, hoarse cry is crying for targeted therapeutic intervention
By Warren R. Heymann, MD, FAAD Nov. 6, 2024 Vol. 6, No. 45 Having recently participated in the excellent conference devoted to antisemitism in medicine organized by Heather Milbar at the University of Pennsylvania, I reacquainted myself with Erich Urbach, who described lipoid proteinosis (LP, Urbach-Wiethe disease) with the otolaryngologist
This month’s news from across the specialty
What’s hot ... November 1, 2025 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Bryan Carroll, MD, PhD, FAAD I don’t see an important word — ‘teledermatology’ — in the title of a recent publication about 3D total-body
Methotrexate toxicity: What’s in a name?
By Warren R. Heymann, MD Aug. 24, 2017 Methotrexate-induced skin toxicity: photographs of 4 illustrative cases. A, Erosions in psoriatic plaques over the torso (patient 1). B and C, Ulcerated and reticulated psoriatic plaques over the arms (patient 2). D, Small shallow cutaneous erosions (patient 4). E, Mucosal erosions over
Ubiquitous ubiquitination
By Warren R. Heymann, MD June 28, 2017 Generalized severe epidermolysis bullosa simplex. Blister classification. Single blisters were defined as a count of 1. Blister nests derived from 1 healing blister were defined as a count of 1. Redness without convexes was not counted. Only time points for which good
This month's news from across the specialty
What's hot ... November 1, 2019 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... EDWARD W. COWEN, MD, MHSc Adalimumab was approved in 2015 for the treatment of moderate and severe hidradenitis suppurativa (HS). It is
Get your KICS on Route IL-6
By Warren R. Heymann, MD March 1, 2018 Hemophagocytic lymphohistiocytosis (HLH) is a syndrome caused by hypercytokinemia (notably Th1 cytokines — interferon-gamma, tumor necrosis factor-alpha, and IL-6). Clinical manifestations are dramatic, presenting as fever, hepatosplenomegaly, hemophagocytosis, and cytopenias. (See the addendum for diagnostic criteria of HLH). Primary forms of HLH
Advocacy Update Aug 19, 2025
IN THIS ISSUE / Aug. 19, 2025 Academy addresses Cigna’s new E/M billing policy AADA member selected for Partnership for Quality Measurement’s Pre-Rulemaking Measure Review Clinician Committee AADA presents at FDA Advisory Panel on dermal fillers Contribute to SkinPAC Payer Advocacy Academy addresses Cigna’s new E/M billing policy ... On
Mpox: Treating severe lesions
Wound care ... Accurate diagnosis of lesions is crucial and should start with an assessment of the patient and potential risk factors for mpox (monkeypox), disease severity, and complications. Risk factors for mpox include history of known or possible exposure, relevant travel and sexual behaviors (e.g., sex associated with commercial
2020 CPT Coding Updates
For 2020, the CPT code set has multiple changes. Although most of the changes do not specifically affect dermatology, there are notable changes that members need to be aware of starting on January 1, 2020. ... Non-Face-to-Face-Services: Telephone Services ... CPT code 99444 has been deleted and in its place,
Nailing the diagnosis of the BAP1 tumor predisposition syndrome
By Warren R. Heymann, MD, FAAD June 5, 2024 Vol. 6, No. 23 I never imagined that I would be writing another commentary on onychopapillomas (Ops) so soon. The initial commentary was devoted to rare malignant Ops. (1) Unsurprisingly, additional reports of malignant Ops have been reported. (2) What else
Melanoma in situ: The power of one (centimeter)?
By Warren R. Heymann, MD Sept. 10, 2016 I remember Marie. She was a delightful elderly woman whom I would see for routine follow-up following an excision of her melanoma in situ (MIS) from her right arm. I will never forget my astonishment upon feeling the large lymph node in
Coughing up a new warning for ustekinumab
By Warren R. Heymann, MD May 15, 2019 Vol 1, No. 10 After using a drug for years, physicians become comfortable with the benefits and risks of the frequently prescribed agent. I have utilized ustekinumab extensively — learning of new adverse reactions is sobering. ... Ustekinumab has been in use
July 24, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 24, 2024 ... Is there an association between benzoyl peroxide use and increased blood benzene levels? DermWorld Insights and Inquiries : Pancreatic panniculitis — Getting spooked by ghost cells AADA
Types of audits
RAC audits: In a nutshell ... There are four different types of Medicare contractors that are responsible for auditing records, claims, and payments. ... You need to notify your MAC if you notice errors during a self-audit. ... It doesn’t matter whether you are being audited for the first time
A potential roadMAP for treating malignant atrophic papulosis
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, June 1, 2026 Vol. 8, No. 6 Certain skin lesions evoke dread in the dermatologist who encounters them, fearing a poor prognosis for their patient. Examples include a Sister Mary Joseph nodule, a thick melanoma, or rhinocerebral mucormycosis, among
This month’s news from across the specialty
What’s hot ... August 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MS, MPH, FAAD SARMs is a growing and dangerous social media trend. ... The U.S. Food and Drug Administration (FDA)
CMS releases 2024 third and fourth quarter NCCI edits
Derm Coding Consult ... By Tiffany E. McFarland, RHIT, Analyst, Coding & Reimbursement, February 1, 2025 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . CMS has released the third and fourth quarter updates to the 2024 National
This month’s news from across the specialty
What’s hot ... May 1, 2022 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MPH, MSBS, FAAD Prior authorization (PA) is purportedly designed to promote evidence-based care and prevent overuse of health services that
Firefighter Skin Cancer Checks Program on a ladder to success
On June 1, the Academy launched its new ... Firefighter Skin Cancer Checks Program nationally. Developed in partnership with the Firefighter Cancer Support Network, the new program aims to provide help to a population that is at a much greater risk of melanoma and skin cancer than the average person.
Advocacy Update Feb. 18 2025
IN THIS ISSUE / Feb. 18, 2025 AADA, house of medicine demand reversal of Medicare cut and provide a pay boost AADA highlights need for Medicare physician payment reform at House Committee on Ways and Means hearing Dermatology addresses new CLIA requirements for lab directors Legislators reject pharmacists’ effort to
Advocacy Update Mar. 18, 2025
IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key
This month’s news from across the specialty
What’s hot ... July 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD, FAAD Need a refresher on optimizing CPT coding and documentation? At this year’s AAD Annual Meeting lecture on Coding and
The congenital perineal groove: Defective recognition of a dermal defect
By Warren R. Heymann, MD ... Feb. 28, 2018 ... It has been nearly half a century since Stephens first detailed the perineal groove (PG) as a congenital malformation consisting of three features: (1) a wet groove in the midperineum between the fourchette and the anus; (2) normal formation of
CMS releases 2025 third and fourth quarter NCCI edits
Derm Coding Consult ... By Tiffany E. McFarland, RHIT, CPCD, CRCR Analyst, Coding & Reimbursement, March 1, 2026 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . CMS has released the third and fourth quarter updates to the
AADA takes on step therapy reform, sunscreen access
New Jersey Gov. Phil Murphy (D) signed step therapy reform legislation into law, effective Jan. 1, 2026. The new law places guardrails around the use of step therapy protocols by state-regulated health plans, including Medicaid. ... The AADA has supported this effort since 2020 in partnership with the Dermatological Society
Danger in the workplace
Occupational associations of skin cancer ... Feature ... By Emily Margosian, Assistant Editor, March 1, 2023 In 1775, English physician Sir Percivall Pott made history, publishing the first report of cancer caused by occupational exposure. Pott had noted an unusually high incidence of skin sores on men working as chimney
Improvement activities (15%)
In this performance category, clinicians are rewarded for care focused on care coordination, beneficiary engagement, and patient safety. For 2025 MIPS reporting, this category is worth 15% of the MIPS score with a maximum of 40 points available. There are 77 dermatology-relevant practice improvement activities (IAs) to choose from. ...
Guidelines for the management of hidradenitis suppurativa
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, August 1, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Christopher Sayed, MD, about his
The many uses of microneedling
Go to AAD Home ... Go to AAD Home ... Menu ... How it works, potential applications, and what patients should know ... How it works, potential applications, and what patients should know ... By Emily Margosian, assistant editor Once an experimental treatment pioneered through the use of tattoo pistols
A Frank discussion about earlobe creases
By Warren R. Heymann, MD, FAAD Dec. 14, 2022 Vol. 4, No. 49 A half-century has transpired since Sanders T. Frank reported: "All patients 60 years of age or younger who had a positive ear-lobe sign [characterized by a prominent crease in the lobule portion of the auricle] were studied
Labor Day thoughts on increasing dermatologist burnout
By Warren R. Heymann, MD Sept. 5, 2016 "Love and work…work and love. That’s all there is" – Sigmund Freud ... Today you probably received an email from ... Dermatology Times entitled "Tips for taking advantage of Labor Day 2016." A recent Mayo Clinic study was quoted, noting that between
A medal-worthy diagnosis: Medallion-like dermal dendrocyte hamartoma
By Warren R. Heymann, MD, FAAD Aug. 30, 2023 Vol. 5, No. 35 A personal joy of dermatology is rendering a diagnosis in a lesion or rash that I have only read about but never previously encountered in practice. Beyond being intellectually satisfying, having a precise diagnosis is reassuring, as
Trichophyton rubrum resistant to terbinafine
Trichophyton rubrum resistant to terbinafine ... T. rubrum , a dermatophyte fungus, is the most common cause of dermatophytosis worldwide. ... 1 ... Oral terbinafine is considered a first-line treatment for most infections caused by this fungus, but cases of terbinafine-resistant ... T. rubrum are increasingly being reported worldwide and
This month’s news from across the specialty
What’s hot ... June 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Christen Mowad, MD, FAAD The American Academy of Dermatology SPOT Skin Cancer™ program has been very well received and provides a community service
New CDC treatment guidelines for sexually transmitted infections
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, May 1, 2022 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Kimberly A. Workowski,
AADA advocacy delivers Senate Medicare payment reform bill
In a major advance in AADA’s fight for Medicare payment reform, the Senate introduced a bill on Aug. 1 aimed at addressing budget neutrality, a major cause of the ongoing physician payment cuts. This is a direct result of the AADA’s relentless advocacy on this issue, which is our sole
Skin cancer fact sheet
Incidence rates ... Skin cancer is the most common cancer in the United States. (1-3) ... Current estimates are that one in five Americans will develop skin cancer in their lifetime. (4) ... It is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day.
Selectivity and the choice of beta-blockers for infantile hemangiomas
By Warren R. Heymann, MD Sept. 11, 2017 Clinical evolution of an infantile ulcerated hemangioma on upper lip of patient 7. Clinical appearance: Before starting propranolol (A); after 12 months of follow-up (3 months of treatment) (B). ... Credit: ... JAAD Has there ever been a more radical change in
August 21
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 21, 2019 ... FDA grants breakthrough therapy designation to advanced melanoma treatment DW Insights and Inquiries : Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections Quality
March 6, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 6, 2024 ... Benzyl benzoate vs. permethrin in treating scabies DermWorld Insights and Inquiries : Hemochromatosis — Beyond 50 shades of gray Oral acitretin plus topical triamcinolone vs. topical triamcinolone
Biting my nails worrying about atypical presentations of nail unit melanomas
By Warren R. Heymann, MD March 27, 2019 Vol. 1, No. 3 I recently encountered a patient who expressed his disappointment in me, complaining that I was too slow to diagnose a lentigo maligna in a facial solar lentigo that we had been following. How could I miss a melanoma?
Vulvar hidradenoma papilliferum and mammary-like gnogenital glands: The whole story
By Warren R. Heymann, MD July 31, 2016 I had always assumed that hidradenoma papilliferum (HP), which characteristically appears in the vulvar region, was derived from apocrine glands. Until I read the article by El-Khoury et al (1) I had never even heard of mammary-like anogenital glands (MLAGs). ... Although
Preventing and treating Trichophyton indotineae
Prevention ... Specific recommendations to prevent ... T. indotineae infection do not exist, but physicians can educate patients about strategies for ... preventing dermatophyte infections in general. ... Health care professionals should use ... Standard Precautions when caring for patients with possible tinea. ... Empiric treatment ... Because confirmatory testing
October 27, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 27, 2021 ... COVID-19 and nails: A review of clinical findings DermWorld Insights and Inquiries : Taking woolly hair to heart Derm Coding Consult : CMS revises Advance Beneficiary Notice
Key messages for social media about hair loss
Key messages ... Many conditions and diseases can result in hair loss, as can improper hair care. ... The most common cause of hair loss is hereditary thinning or baldness, also known as androgenetic alopecia. (1) This condition affects an estimated 80 million Americans — 50 million men and 30
American Academy of Dermatology survey shows outdoor workers more at risk for skin cancer than average Americans
Board-certified dermatologist encourages those who work outside to utilize proper sun protection ROSEMONT, Ill. (May 7, 2024) — A recent American Academy of Dermatology survey of more than 1,000 U.S. adults revealed that outdoor workers — like those who work in construction, landscaping, emergency medical services, and postal delivery —
Eccrine syringofibroadenoma: Sweating over the details
By Warren R. Heymann, MD, FAAD January 26, 2022 Vol. 4, No. 4 While learning about rare entities during our training, we may wonder if we will ever encounter the disorders in "real life." Eccrine syringofibroadenoma (ESFA), first described in 1963 by Mascaro, was considered a relatively "new" lesion when
Brentuximab vedotin update and the #MeToo saga of the Reed-Sternberg cell
By Warren R. Heymann, MD Jan. 1, 2018 Myxoinflammatory fibroblastic sarcoma. High-power view showing large Reed-Sternberg–like cells (A) and mitotic figures (B). ... Credit: ... JAAD There has been increasing dermatological literature about the use of brentuximab vedotin (BV) for a variety of CD30+ cutaneous lymphomas. The thrust of this
August 8, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 9, 2023 ... Emerging treatments for itch in atopic dermatitis DermWorld Insights and Inquiries : Prior authorization audits and innovations — Are we finally reducing the (PA)in? Adverse events in
Topical retinoid therapy for acanthosis nigricans: In the thick of it
By Warren R. Heymann, MD Dec. 11, 2019 Vol. 1, No. 39 At the risk of overgeneralizing, in my experience there are two types of patients with acanthosis nigricans (AN) — those who are devastated by it, and those are unaware that they have it. ... This commentary will focus
Reflectance confocal microscopy, driverless cars, and Uber: The future of dermatopathology
By Warren R. Heymann, MD ... Sept. 12, 2016 ... In a matter of days, you will be able to use Uber to hail a driverless car to your destination in Pittsburgh. During these trials, initially there will be a human monitor (1). You know where this is going
Joining the bullae pulpit: PD-1 inhibitors
By Warren R. Heymann, MD Aug. 25, 2016 As the use of immune checkpoint inhibitors has increased, so have the number of severe immunotherapy-related adverse events (irAEs). Although discontinuation of therapy may result in resolution of these untoward reactions, long-term sequelae and death have been reported. In a recently published
Getting to the heart of neonatal lupus erythematosus
By Warren R. Heymann, MD, FAAD July 21, 2021 Vol. 3, No. 29 I have found that rendering the diagnosis of neonatal lupus erythematosus (NLE) is fraught with emotional challenges. Not only are mothers concerned for their children, frequently they are unaware of the fact that they are also at
Melanoma clinical guideline
More than 1 million people are living with melanoma, and one person dies of the disease every hour. These new evidence-based guidelines address the most commonly considered and utilized approaches for the surgical and medical treatment of primary cutaneous melanoma. Review guideline highlights or download the full guidelines below. ... Access
September 6, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 6, 2023 ... Chemoprevention of keratinocyte carcinoma with imiquimod, 5-FU, and tretinoin DermWorld Insights and Inquiries : Paraneoplastic Merkel cell carcinoma: Searchin' for my lost shaker of salt Vitiligo patients
The risk of melanoma in adults with giant pigmented nevi
By Warren R. Heymann, MD May 27, 2016 Giant pigmented nevi (GPN, defined in reference 1 as > 20 cm in an adult) are among the most challenging lesions from so many perspectives. When diagnosed in childhood, questions from parents regarding the risk of melanoma, approach to monitoring, managing, and
The concept of atrophoderma of pasini and pierini as morphea may be falling off a cliff
By Warren R. Heymann, MD Nov. 6, 2017 ... Clinical photos of idiopathic atrophoderma of Pierini and Pasini. ... Credit: ... JAAD Diagnosing Atrophoderma of Pasini and Pierini (APP) is reasonably straightforward — it usually presents in adolescents and young adults, more often in females, with sharply defined, single or
Teledermatology workflow for small practices
Use the workflow below to help you implement or improve your teledermatology operations. This version is designed for solo or small practices. There is a distinct PDF guide for dermatologists who practice in an ... academic or multispecialty organization . ... 1. Technology setup ... Create a generic account on
Misinformation puts over 16 million Americans at an increased risk for skin cancer
New data from the American Academy of Dermatology reveals misinformation drives adults to cut back or stop using sunscreen Survey data show influence of social media, misconceptions, and gaps in sun safety knowledge – especially among Gen Z Gen Z is flunking sun safety, with one-third scoring a D or
Slammed by slime
By Warren R. Heymann, MD Sept. 16, 2020 Vol. 2, No. 37 Visiting Nickelodeon Studios in Orlando, Florida in the early 1990s was a religious experience for my family. Watching a live recording of ... Double Dare, my daughters were fervently praying to be among the chosen few to be
Keeping dermatologists in the driver’s seat with step therapy reform
Moving the needle ... By Victoria Houghton, Managing Editor, March 1, 2023 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. Step therapy protocols interfere with patient care and create unwanted burdens on dermatology practices. Thanks to the AADA’s
AADA advocates for innovative teledermatology policies and programs
While 85 million Americans are impacted by skin disease, only 1 in 3 patients will see a dermatologist. The Academy believes that teledermatology is a powerful tool for increasing patient access to needed dermatologic care. ... The Academy advocates for innovative teledermatology policies and programs that increase access to care
AMA CPT releases new online digital E/M services codes for private payers
Effective Jan. 1, 2020, the AMA CPT deleted CPT code 99444 (Online evaluation and management service provided by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient or guardian, not originating from a related E/M service provided within the
I have moved. How do I update my contact information with the Academy?
Asked and Answered ... March 1, 2023 AAD members can conveniently update their contact information at any time by visiting account.aad.org and selecting the ‘My Profile’ tab from the menu below. ... For additional assistance, please contact the Member Resource Center at ... mrc@aad.org or 866-503-7546. ... Looking for more
We are battling detrimental Medicare payment cuts
As our top federal legislative priority, your Academy has been fighting all year against Medicare payment cuts of 8.5% or more that are scheduled to begin on Jan. 1, 2023. These scheduled cuts are on top of payment reductions that took effect this year, and, without a long-term solution, Medicare
AESOP: The ants and the grasshopper
By Warren R. Heymann, MD, FAAD Aug. 21, 2024 Vol. 6, No. 34 Unquestionably, AESOP ( ... A denopathy and ... E xtensive ... S kin patch ... O verlying a ... P lasmactyoma) is rare — to date, fewer than 25 cases have been reported. (1) Why write (or
Of every possible solution for elastosis perforans serpiginosa, fractional carbon dioxide laser may be the best
By Warren R. Heymann, MD Nov. 13, 2017 ... Elastosis perforans serpiginosa. Clinical presentation. ... Credit: ... JAAD My initial attraction to dermatology, which still offers great appeal, is the challenge and joy of differential diagnosis and clinical-pathologic correlation. I learned quickly, however, that patients don’t want to be interesting
DermWorld Weekly comparing efficacy of JAK inhibitors used in alopecia areata
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 22, 2023 ... Comparing efficacy of JAK inhibitors used in alopecia areata DermWorld Insights and Inquiries : Resorcinol’s resourcefulness in hidradenitis suppurativa Derm Coding Consult : CMS Targeted Probe and
Coding and documentation — Your best defense
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, October 1, 2025 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Accurate and thorough documentation in the medical
Beyond disfigurement: The potential for keratinocyte carcinoma in discoid lupus erythematosus
By Warren R. Heymann, MD, FAAD Jan. 10, 2024 Vol. 6, No. 2 Cosmetic disfigurement due to scars and dyspigmentation is the main complication of discoid lupus erythematosus (DLE). The current classification of cutaneous lupus erythematosus (CLE) includes acute cutaneous LE (ACLE), subacute LE (SCLE), chronic cutaneous LE (DLE, LE
Clear cell papulosis: Clearly distinctive, clearly underrecognized
By Warren R. Heymann, MD June 3, 2020 Vol. 2, No. 22 One of my greatest joys in dermatology is diagnosing a disease that I have only read about, but then encounter in life. That "aha moment" is exhilarating! When attending patient presentations at dermatology conferences, I encourage my residents
Recognizing Trichophyton indotineae
Reporting to health departments ... Physicians who suspect antimicrobial-resistant dermatophytosis can also contact ... their state or local health departments for assistance . Public health officials who are concerned about potential cases or clusters of drug-resistant tinea infections can email ... fungaloutbreaks@cdc.gov for assistance with recommendations and testing. ... Overview
A Trumpian analysis of infliximab-induced follicular mucinosis: Something’s going on here
By Warren R. Heymann, MD July 10, 2016 Williams et al presented two cases of biopsy-proven facial follicular mucinosis (FM), apparently induced by infliximab, with a normal tissue CD4/CD8 ratio of 2/1 and the presence of CD7, thereby ruling out CTCL. The first case was a 23 year-old man with
Trichophyton indotineae infections and other severe or antifungal-resistant dermatophytoses
Dermatophytosis (ringworm, tinea, jock itch, athlete’s foot) is a very common and typically minor infection of the skin caused by dermatophyte fungi. ... 1 ... In the past decade, severe or antifungal-resistant dermatophytoses have become a global public health concern, including in the United States. ... The AAD has assembled
2024 Allergen of the year: Sulfites
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, April 1, 2024 In this month’s Clinical Applications column, DermWorld ... Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Erin
No Surprises Act
The No Surprises Act (NSA) provides patients with new protections against surprise billing because of insurance network rules. Like other clinicians, dermatologists must follow new NSA rules beginning on Jan. 1, 2022. The rules were issued jointly by HHS and agencies in the Labor and Treasury departments. ... The NSA
What dermatology practices need to know about laws protecting pregnant and lactating employees
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, D.C. ... By Ben Tesdahl, JD, LLM, Jason Qu, JD, and Rob Portman, JD, MPP, September 1, 2024 Every month , DermWorld ... covers legal issues in "Legally Speaking."
What's hot?
What's hot ... May 29, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... You may be surprised to learn that a ... new organ’ in the skin was recently identified.
Medical vs. cosmetic dermatology: Who is doing what?
Facts at your Fingertips ... By Emily Margosian, assistant editor, January 1, 2019 Despite ongoing discussion about the role of cosmetics in the specialty, data from the 2017 AAD Practice Profile Survey indicate that medical dermatology remains the primary focus of dermatology practitioners across all types. However, dermatologists spend the
This month's news from across the specialty
What's hot ... October 1, 2020 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... ED COWEN, MD Why do a small percentage of young and apparently healthy patients with COVID-19 develop life-threatening infection or a Kawasaki syndrome-like
This month’s news from across the specialty
What’s hot ... January 1, 2026 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Jason Lee, MD, FAAD The incidence of melanoma in situ (MIS) has risen sharply in the U.S., surpassing invasive melanoma in 2025 ( ...
Dermatology coding essentials part 2: Reporting dermatology procedures and services
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding & Reimbursement, June 1, 2026 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . Current Procedural Terminology (CPT®) is a code
What is being recommended to patients on social media?
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, October 1, 2023 Social media is abundant with skin care advice. A recent ... JAAD cross-sectional analysis of acne treatments on YouTube found that up to 91% of teens report using social media to access health information. However, who is
The opioid epidemic: Coma blisters and beyond
By Warren R. Heymann, MD Aug. 4, 2017 The opioid crisis in the United States is responsible for at least 90 fatalities every day. This dire situation has been aggravated by the increased availability of very potent synthetic opioids such as fentanyl and carfentanil, which are 50 and 5000 times
This month's news from across the specialty
What's hot ... March 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MPH, MSBS The American Journal of Public Health published a series of analyses on wasteful spending in United States health
Phacing the future: When patients with PHACE syndrome grow up
By Warren R. Heymann, MD June 24, 2020 Vol. 2, No. 25 The acronym PHACE syndrome, emphasizing the characteristic findings of this neurocutaneous syndrome: ... p osterior fossa malformations, ... h emangiomas, ... a rterial anomalies, ... c oarctation of the aorta and cardiac defects, and ... e ye abnormalities,
Pathway to reducing medical errors
By Jason B. Lee, MD, FAAD June 26, 2024 Vol. 6, No. 26 The 2000 landmark report by the Institute of Medicine ... To Err Is Human: Building a Safer Health System ushered in the patient safety movement in the modern era. (1) The report highlighted nearly 98,000 hospital deaths
Homing in on hornerin: Breaking down the barrier to understand its crucial role in atopic dermatitis
By Warren R. Heymann, MD, FAAD Oct. 16, 2024 Vol. 6, No. 42 Atopic dermatitis (AD) is characterized by skin barrier dysfunction, inflammation, and chronic pruritus. The etiology of AD, however, is complicated and incompletely understood, with genetic, environmental (soaps, surfactants, stress), and immunological factors causing skin barrier abnormalities and
Impact Report — Vol 6, Issue 1
Your membership in action From fighting for your patients and practice against payment cuts and scope-of-practice expansions, to securing major media wins that position you as the authorities in skin, hair, and nails, see how your Academy is working for you. Plus, explore the latest member benefits, including new CME
Scar solutions
Experts discuss current approaches to scar management. ... Feature ... By Emily Margosian, Assistant Editor, January 1, 2025 Every scar has a story. However, for millions of people worldwide, scars may negatively impact their quality of life, causing psychological distress along with physical discomfort. ... While therapeutic approaches to treat
Striae due to bartonella is a stretch
By Warren R. Heymann, MD May 1, 2018 ... A, Localized striae distensae on the left upper limb (flexor aspect). B, Clinical improvement 9 weeks after treatment. ... Credit: ... JAAD I met a woman in her early 20’s who is being treated for chronic Lyme disease and Bartonella infections
Estate planning 101
Experts offer tips on what to do and when to do it. ... Feature ... By Ruth Carol, Contributing Writer, March 1, 2023 They are two of the most difficult decisions to make: who should be your child’s guardian and who should get your assets if something happens to you.
Impact Report — Vol 5, Issue 1
Reiterating the value of membership It’s time once again for the Academy’s ... Impact Report to reveal its 2024 advocacy and patient education activities and remind you of your meaningful member benefits from last year. ... Read the latest on how we are advocating for you on Capitol Hill and
JAAD ranks no. 1 among dermatology journals
The Journal of the American Academy of Dermatology’s ... impact factor increases by 34% ROSEMONT, Ill. (July 5, 2022) — The ... Journal of the American Academy of Dermatology is the top peer-reviewed journal in its field, according to the 2021 journal impact factor rankings recently published by Clarivate’s Journal
Senile gluteal dermatosis: The term “senile” is getting old and should be retired
By Warren R. Heymann, MD, FAAD Jan. 24, 2024 Vol. 6, No. 4 As my patients and I get older, inevitably I think more about geriatric dermatology. (1) There is a disorder I have seen on the gluteal region in mostly thin, older, sedentary patients — my recommendations of off-loading
Americans lack basic health insurance literacy
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, March 1, 2023 A recent Forbes Advisor survey of 2,000 Americans who have health insurance found that while most policyholders report they’re happy with their coverage, many don’t understand it.According to the survey, over three-quarters of participants were unable to
Problematic in pregnancy?
Dermatologists discuss the safety of common dermatologic drugs in pregnant patients. ... Feature ... By Jan Bowers, Contributing Writer, June 1, 2023 Few mourned the end of the FDA’s pregnancy risk letter categories for prescription and biologic drug labeling in 2015. In addition to being an oversimplified distillation of available
March 24, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 24, 2021 ... Derm Coding Consult : Applying 2021 E/M coding concepts in everyday practice — Part 1 DermWorld Insights and Inquiries : Lipschütz ulcers — Not only for women
Coming to grips with lymphocytic thrombophilic arteritis
By Warren R. Heymann, MD, FAAD May 18, 2022 Vol. 4, No. 20 As a medical student, I was introduced to the concept that bilaterally symmetrical palpable purpura is leukocytoclastic vasculitis until proven otherwise. Although that bromide has served me well over the years, with experience, vasculitis perpetually befuddles me.
Modifier madness
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, April 1, 2019 Test your knowledge: Modifier madness ... Take the quiz to see if you're up to date.
So many questions. So little time.
Experts offer best practices on efficiently addressing patients’ questions about sunscreen. ... Feature ... By Andrea Niermeier, April 1, 2023 Aisles of products, numerous social media top 10 lists, and abundant information on the internet: Consumers can be quickly overwhelmed with sunscreen questions related to types, usage, and safety —
A bridge from the view: Switching from glass to digital dermatopathology
By Warren R. Heymann, MD Nov. 23, 2016 Eight months ago, I started using the Clearpath digital dermatopathology system developed by Tom Olsen and his associates at the Dermatopathology Laboratory Central States (DLCS). As one of the early utilizers, I was grateful to work with his software wizards, offering my
Documentation and reporting requirements for adjacent tissue transfer or rearrangement
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, June 1, 2025 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Adjacent tissue transfer (ATT) or rearrangement procedures
Getting the GIST cutaneous hyperpigmentation disease
By Warren R. Heymann, MD Nov. 6, 2019 Vol. 1, No. 35 Gastrointestinal stromal tumors (GISTs) are mesenchymal malignancies arising from the interstitial cells of Cajal (cells that create bioelectrical slow wave potential, leading to smooth muscle contraction, thereby aiding peristalsis). GISTs were initially recognized by identification of KIT (CD117)
The H syndrome – Understanding Y
By Warren R. Heymann, MD April 15, 2020 Vol. 2, No. 15 It has been more than a decade since the H syndrome was described by Molho-Pessach et al, in their report of 10 patients from 6 Arab consanguineous families. (1) More than 100 cases have now been reported worldwide.
Checking in on immune checkpoint inhibitors
Immune checkpoint inhibitors offer hope for non-melanoma skin cancer patients ... Feature ... By Heidi Splete, Contributing Writer, July 1, 2022 Patients with advanced non-melanoma skin cancer see new hope on the horizon, thanks to recent developments in the number and effectiveness of new drugs to improve survival. ... "Patients
Reporting Mohs micrographic surgery with a simple repair
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Coding & Reimbursement, February 1, 2022 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . The Integumentary System, Repair (Closure) guidelines were recently
Peace of mind
Finding the right insurance coverage to protect your practice. ... Feature ... By Andrea Niermeier, Contributing Writer, September 1, 2024 While the adage goes, "By failing to prepare, you are preparing to fail," this simple witticism has grown complicated for dermatologists looking to protect themselves, their practices, and their patients.
A tale of two disorders of hypopigmentation: The potential role of Cutibacterium acnes dysbiosis in progressive macular hypomelanosis and lichen striatus
By Warren R. Heymann, MD, FAAD April 30, 2025 Vol. 7, No. 17 The human microbiome of the skin, gastrointestinal tract, and airways comprises distinct populations of bacteria, fungi, viruses, and mites and plays an essential role in homeostasis. The skin microbiome represents the totality of microbial genes within the
Dupilumab treatment of bullous pemphigoid: Hoping for approval on the double
By Warren R. Heymann, MD, FAAD Jan. 15, 2025 Vol. 7, No. 2 Perhaps dupilumab won’t be the game-changing biologic that patients are pining for. At the least, it represents the dawn of the biologic era for AD [atopic dermatitis] ... . That alone offers hope for our long-suffering patients,
A niche within NICH
By Warren R. Heymann, MD February 26, 2020 Vol. 2, No. 8 Just when I thought I grasped the concept of congenital hemangiomas, new data raises novel questions. ... Compared to infantile hemangiomas that grow rapidly after birth and then involute, congenital hemangiomas arise and proliferate in utero. Although two
The treatment of systemic juvenile xanthogranulomas matures
By Warren R. Heymann, MD, FAAD Jan. 8, 2025 Vol. 7, No. 1 Diagnosing juvenile xanthogranulomas (JXG) is simultaneously satisfying and slightly disconcerting. JXG’s clinical yellow appearance, the "setting sun" on dermoscopy, or the recognition of Touton giant cells histologically allows dermatologists to be reasonably confident of the diagnosis. It
Stress^2 + Hormones^2 = Acne^2
By Warren R. Heymann, MD June 5, 2019 Vol. 1, Issue 13 I would wager that every human being has experienced at least one pimple attributed to stress. I recall a devastatingly embarrassing moment during 10th grade world history class at Martin Van Buren High School (Queens, New York), when
Ergonomics in dermatology
Neck, back, shoulder pain? It could be your exam table. ... Feature ... By Ruth Carol, Contributing Writer, January 1, 2025 After investing an average of 12 years of education and training, the last thing a dermatologist wants is to have their career cut short by musculoskeletal disorders (MSDs). However,
Measuring a lesion and choosing the appropriate excision code
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, June 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Benign and malignant lesions present significant
Tackling itch
Understanding and treating chronic itch ... Feature ... By Allison Evans, Assistant Managing Editor, April 1, 2022 Itch, or pruritus, is a common symptom (and condition) that is considered one of the 50 most prevalent conditions worldwide — an estimated 15% of the population suffers from chronic pruritus. Speak to
Is dyshidrosiform pemphigoid really anti-p200 pemphigoid?
By Warren R. Heymann, MD Aug. 20, 2016 Dyshidrosiform pemphigoid (DP) was initially reported in a 72 year-old man with large, tense bullae on the plantar aspect of his feet, with some lesions on an erythematous base. He also had an "ill-defined papular eruption" of the trunk and an erosion
February 8, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 8, 2023 ... A review of newer agents for alopecia areata DermWorld Insights and Inquiries : A surgeon’s primary intention is to reduce secondary infection CDC investigating possibility of treatment-resistant
September 14, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 14, 2022 ... Real-world methotrexate use in pediatric patients with plaque psoriasis DermWorld Insights and Inquiries : The ever-changing world of nevus sebaceus New anti-wrinkle injection receives FDA approval FDA
Disaster relief preparedness
Answers in Practice ... By Swapna Pachauri, MPH, manager, Health Technology & Informatics, June 1, 2021 Each month DermWorld ... tackles issues "in practice" for dermatologists. This month Swapna Pachauri, MPH, the Academy’s Health Technology & Informatics manager, offers a summary of disaster relief preparedness. Disasters and emergencies can happen
Quality Resources Provided by the AAD
Quality Measures ... AAD continues to develop ... dermatology-specific measures available to dermatologists . Dermatology measures are needed to meet CMS reporting requirements, can be used to drive quality improvement, and may be required by additional organizations. ... Learn more about quality measures available for reporting, a ... measure selection
Pineapple and cicatricial pemphigoid: A need to dole out more studies
By Warren R. Heymann, MD Oct. 4, 2016 The benefits of pineapples have been touted in folk medicine for years. Increasing knowledge of its active ingredient bromelain has lead to a therapeutic pineapple renaissance. Bromelain is a complex natural mixture of proteolytic enzymes derived from pineapple (Ananas cosmosus) and possesses
Idiopathic facial aseptic granuloma — Have we met?
By Warren R. Heymann, MD July 20, 2017 I’m racking my brain wondering if I have ever seen a case of idiopathic facial aseptic granuloma (IFAG) — I know that I never made the diagnosis because I had never heard the term until I read the first reference. I surmise
The woolly culprit: Lanolin revealed as an uncommon cause of dermatitis on normal skin
By Christen Mowad, MD, FAAD Nov. 15, 2023 Vol. 5, No. 46 Excitement surrounding the "Allergen of the Year" may only be truly appreciated by those immersed in the field of contact dermatitis and patch testing, but each year the announcement is met with enthusiasm from the wider dermatology specialty.
2025 CPT coding updates
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, December 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . The American Medical Association (AMA) has
Isotretinoin and diabetes: Of familiarity and surprise
By Warren R. Heymann, MD, FAAD July 6, 2022 Vol. 4, No. 27 On a gloriously sparkling, warm spring afternoon in 2009 I sat with my family in the right field bleachers of the new Yankee Stadium as the Bronx Bombers took on the Phillies. I relished the expansive majesty
Increasing evidence for the use of topical timolol for pyogenic granulomas
By Warren R. Heymann, MD May 16, 2016 There are multiple approaches to treating pyogenic granulomas (PGs). If possible, I usually perform a shave biopsy and electrodesiccate the base of the lesion. Certainly there are times when that approach may not be optimal, such as a PG the face of
Keeping abreast of drug-induced cutaneous lupus
By Warren R. Heymann, MD, FAAD Aug. 4, 2021 Vol. 3, No. 31 Tom Hanks, as Commander Jim Lovell in the movie ... Apollo 13, lamented that the world was not watching their onboard video, compared to Neil Armstrong’s moon landing a year earlier. Reality dictates that the seminal breakthroughs
Striving to alleviate the physical and emotional scars of central centrifugal cicatricial alopecia
By Warren R. Heymann, MD November 4, 2020 Vol. 2, No. 44 More than half a century ago, Drs. Lopresti, Papa, and Kligman coined the term "hot comb alopecia," asserting: "The cause is unmistakable, namely the practice of straightening the hair with a hot comb…" (1). Now known as central
Are you a rash whisperer?
Go to AAD Home ... Go to AAD Home ... Menu ... Patch test. Identify allergens. Avoid them. If only it was that simple to diagnose and treat patients with allergic contact dermatitis. ... Patch test. Identify allergens. Avoid them. If only it was that simple to diagnose and treat
2026 CPT coding updates
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, January 1, 2026 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . The Centers for Disease Control and Prevention
Coding and documentation for hyperhidrosis
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, November 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Clear and concise documentation is essential
Getting a toehold on subungual tumors: Aneurysmal bone cysts join the club
By Warren R. Heymann, MD Aug. 26, 2016 Subungual tumors make me nervous. I realize that most are benign (subungual exostosis, osteochondroma, onycholemmal cyst, glomus tumor, pyogenic granuloma, wart, fibroma, acral fibromyxoma), however subungual malignant lesions (squamous cell carcinoma, keratoacanthoma, melanoma) occur. A delayed diagnosis can result in a profoundly
Taking it on the shin: Part two
By Warren R. Heymann, MD, FAAD June 7, 2023 Vol. 5, No. 23 Last week ... pretibial pruritic papular dermatitis was reviewed as an underrecognized entity on the shins. Today the focus is on obesity-associated lymphedematous mucinosis (OALM), another disorder that you have likely seen, but perhaps did not recognize.
Step 1: Check participation requirements
MIPS 2026 Reporting Snapshots ... Access our 2026 ... MIPS reporting options (PDF), with guidance tailored to your practice size and needs. ... First, determine if you are exempt from MIPS reporting. ... Use the tool below to check whether you are required to participate in MIPS. CMS uses your
A pandemic of perception
Virtual life has negatively affected patients’ self-perception. Dermatologists may be in a position to help. ... Feature ... By Allison Evans, Assistant Managing Editor, July 1, 2022 Photo editing, once associated with flawlessly airbrushed celebrities, has become not only ubiquitous but nearly a requirement of social sharing. In a highly
Giving thanks
From the President ... Dr. Desai served as Academy president from March 2024 to March 2025. ... By Seemal R. Desai, MD, FAAD, November 1, 2024 Dear members, ... I hope everyone is enjoying their autumn so far! ... Last month kept me busy doing one of my favorite things:
2022 CPT coding updates
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Coding & Reimbursement, November 1, 2021 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . The American Medical Association (AMA) has released the
Resorcinol’s resourcefulness in hidradenitis suppurativa
By Warren R. Heymann, MD, FAAD March 22, 2023 Vol. 5, No. 12 Management of hidradenitis suppurativa (HS) is challenging, including medical and surgical approaches, which are often combined for best outcomes. Lifestyle changes, pain management, and emotional/psychiatric issues must be addressed. Therapeutic approaches include the use of topical therapies
Coding and documentation clarity
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, April 2, 2018 You biopsy a suspected drug eruption and document the following: "Punch biopsy done. Return in 1
This month's news from across the specialty
What's hot ... December 1, 2020 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Harry Dao Jr., MD Choice and transparency dominate our landscape. It is hard to believe that it was only 2013 when the FDA
Coming clean on chlorhexidine-induced dermatoses
By Warren R. Heymann, MD, FAAD March 13, 2024 Vol. 6, No. 11 Dermatologic surgeons use a variety of products that may cause an irritant or allergic contact dermatitis, including antiseptics, anesthetics, gloves, suture materials, tissue adhesives, topical antibiotics, and bandages. Antiseptic agents are the most frequent cause of contact
Vascular abnormalities in FFA, artificial intelligence, and Winston Churchill
By Warren R. Heymann, MD, FAAD Aug. 23, 2023 Vol. 5, No. 34 If Winston Churchill were a dermatologist, he would say that frontal fibrosing alopecia (FFA) is "a riddle wrapped in a mystery inside an enigma" (which is how he viewed Russia). Almost 30 years have passed since Kossard
Sparking the interest in Spark nevus
By Jason B. Lee, MD, FAAD Dec. 13, 2023 Vol. 5, No. 49 The late A. Bernard Ackerman has described and named a variety of dermatologic entities, expanding the lexicon of dermatology over his career. He has been known to come up with catchy and playful names for dermatologic entities
Eye-opening news about oxymetazoline
By Warren R. Heymann, MD, FAAD April 27, 2022 Vol. 4, No. 17 Certain articles have a "wow" factor that immediately impacts practice. In 2007, I recall being impressed by the 2 cases of erythematotelangiectatic rosacea reported by Shanler and Ondo that dramatically improved with the application of oxymetazoline hydrochloride
Cutaneous complications of immune checkpoint inhibitors
DermWorld highlights some of the common (and not-so-common) skin complications associated with ICIs and shares expert tips for management. ... Feature ... By Heidi Splete, Contributing Writer, March 1, 2024 Immune checkpoint inhibitors (ICIs) are a mainstay of immunotherapy for many cancer types — including breast, colon, liver, lung, skin,
This month's news from across the specialty
What's hot ... November 1, 2021 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MPH, MSBS, FAAD Health care support workers (phlebotomists, medical assistants, licensed practical nurses, nursing aides, and medical secretaries) are essential
May 22, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 22, 2024 ... Dermatologic findings associated with semaglutide use DermWorld Insights and Inquiries : Striving to avoid an amebic nightmare — Recognizing cutaneous Balamuthia mandrillaris infection Characteristics and treatment of
Applying the 2021 E/M coding concepts in everyday practice – Part 2
In our ongoing efforts to help members navigate the E/M changes in a simplified and relatable manner in everyday practice, part two of the AADA’s clinical vignettes focuses on the application of the concepts necessary to support reporting a high level of number and complexity of problems addressed, data analyzed,
ICD-10-CM diagnosis coding updates for 2024
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, September 1, 2023 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . The CDC and the National Center
After 23 years, a syndrome converted me into an eflornithine believer
By Warren R. Heymann, MD, FAAD July 12, 2023 Vol. 5, No. 28 I learned that Vaniqa (eflornithine - ... α -difluoromethylornithine [DFMO]) was discontinued. Topical eflornithine was released in 2000 to reduce facial hirsutism. When the drug was released, I recall being fascinated by the premise of its mechanism.
Could a metal implant affect your skin?
Board-certified dermatologist weighs in on the role of metal allergies in medical implants NEW ORLEANS (March 17, 2023) — Millions of people in the U.S. report having a metal allergy, and current estimates state that 10 percent of Americans will receive a medical implant during their lifetime ... 1 ...
This month's news from across the specialty
What's hot ... January 1, 2022 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Sylvia Hsu, MD, FAAD Diagnostic conundrums are often presented at dermatology teaching conferences in which the presenter asks the audience for a differential
This month’s news from across the specialty
What’s hot ... October 1, 2025 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Rosalie Elenitsas, MD, FAAD Pathologists and dermatopathologists frequently encounter poorly differentiated tumors that fail to reveal a defined lineage. In cutaneous specimens, these are
All you need is love.
From the Editor ... Dr. Heymann is the physician editor of ... DermWorld . ... By Warren R. Heymann, MD, FAAD, February 1, 2026 In February 1979, the month before my match in internal medicine, I was struck by Cupid’s arrow during my dermatology elective, which changed the trajectory of
Melanoma of the head and neck: Mohs or wide local excision?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, April 1, 2020 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Ian Maher, MD, about his
Safety first
From the Editor ... Dr. Heymann is the physician editor of ... DermWorld . ... By Warren R. Heymann, MD, FAAD, March 1, 2026 Anyone who has taken a cruise knows the drill: Before heading to the pool, casino, or bar, you must learn to put on your life vest
Do genetics play a role in sun-seeking behavior?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, August 1, 2021 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Veronique Bataille, MD,
Managing hair loss
What has research revealed about the pathogenesis of androgenetic alopecia, alopecia areata, and central centrifugal cicatricial alopecia as well as new potential therapeutics? ... Feature ... By Allison Evans, assistant managing editor, September 1, 2021 To those outside the world of dermatology, hair is sometimes perceived to be a cosmetic
They never taught us how to fail
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, December 1, 2019 Physicians are high performers and success is the norm. In our safety-conscious world of medicine, we learn about errors and are given tools to analyze the root cause in
Advocacy Update Oct 28, 2025
IN THIS ISSUE / Oct. 28, 2025 CMS lifts hold on Medicare claims Advocacy win: Elevance expands coverage for home-based light therapy AAD statement on FDA safety alert for RF microneedling devices AADA nominates Alina Bridges, DO, FAAD, for Medicare clinical diagnostic laboratory test advisory panel 2026 Advocate of the
Cocaine-associated plasma cell orificial mucositis: Anything goes
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, April 1, 2026 Vol. 8, No. 4 Dermatologists will never be bored by cocaine. The mucocutaneous manifestations are so vast that one can almost say that "anything goes," but there are clinical scenarios where clinicians should suspect cocaine use
Twenty years of imiquimod taking its toll on lentigo maligna — Where are we?
By Warren R. Heymann, MD February 12, 2020 Vol. 2, No. 6 Although Y2K never amounted to much, a solitary case report that year changed the dynamic in treating a vexing problem — melanoma in situ of the lentigo maligna (LM) subtype. Ahmed and Berth Jones reported treating an 88-year
March 27, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 27, 2024 ... Spironolactone: Risk of breast, gynecologic malignancies? DermWorld Insights and Inquiries : Always another worry for patients with hidradenitis suppurativa — Amyloid A amyloidosis FDA approves spesolimab for
Cosmetic complications
Dermatologists offer insight and instruction for approaching procedural afflictions. ... Feature ... By Laura Vernaci, Contributing Writer, September 1, 2025 It goes without saying that dermatologists do everything in their power to keep their patients safe and avoid complications or adverse events. However, stay in the business long enough and
Fighting for truth in advertising in Indiana
Ask the Expert ... By Victoria Houghton, Managing Editor, August 1, 2022 DermWorld ... spoke to Carrie Davis, MD, FAAD, former chair of the Government Affairs and Advocacy Committee at the Indiana Academy of Dermatology, about efforts with the American Academy of Dermatology Association (AADA) to advocate for truth in
2024 CPT coding updates
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, November 1, 2023 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . The American Medical Association (AMA) has
Dermatological Care MIPS Value Pathway (MVP)
The Dermatological Care MIPS Value Pathway (MVP) is a streamlined reporting system designed specifically for dermatologists to meet MIPS requirements. CMS is designing MVPs to allow physicians to report on measures that are more relevant to their specialties in a structured manner. Unlike traditional MIPS, participation in an MVP for
Prolactin and its role in stress-induced psoriasis: Milking the data
By Warren R. Heymann, MD Jan. 18, 2018 Patients will readily acknowledge that stress worsens their psoriasis. When asked how this happens, I respond by mentioning the "mind-body connection" using the term "psychoneuroimmunology;" patients nod in agreement, feigning understanding; appropriately so, because frankly, I don’t understand it either. ... The
Positively perplexing: Determining the meaning of CD30 positivity
By Warren R. Heymann, MD, FAAD Sept. 29, 2021 Vol. 3, No. 39 I’ll wager that most readers of DWI&I have experienced receiving a biopsy report, obtained from an inflammatory lesion, stating "scattered CD30+ cells were observed," accompanied by a comment that "clinicopathologic correlation is necessary to rule out the
Optimizing melasma management
Experts discuss treatment strategy, new insights into pathogenesis, and emerging therapies. ... Feature ... By Emily Margosian, Senior Editor, March 1, 2026 Pigmentary disorders represent some of the most common cutaneous concerns globally. In the U.S. alone, melasma affects more than 5 million people (doi:10.1016/j.jaad.2010.12.046). ... While primarily a cosmetic
It's time for a CLIA refresher!
In Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, August 1, 2019 What comes to mind when you hear CLIA? Probably that it’s just another burdensome federal regulation
We all know.
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, FAAD, October 1, 2024 Ask any of us and we will confidently claim that no one knows more about skin, hair, and nails than a board-certified dermatologist. Unfortunately, social media offers an
AADA advocacy at a state level
From the President ... Dr. Taylor is the Academy’s former president. ... By Susan C. Taylor, MD, FAAD, February 1, 2026 Taking care of dermatologists so that they can take care of their patients...and their practices Dear members, ... Advocacy is a key mission of the Academy. On the federal
Do polygenic risk scores have potential utility in determining risk for dermatologic disease?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, February 1, 2020 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Maryam Asgari, MD, MPH, about
This month’s news from across the specialty
What’s hot ... January 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD, FAAD In October’s ... Dialogues in Dermatology , Dr. Scott Elman, double board-certified internist and dermatologist, discusses important "new medications
Key components of evaluation and management: Medical decision making
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, August 1, 2018 Medical decision making (MDM) is the third key component of evaluation and management (E/M) that is
Key components of evaluation and management: Physical examination
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, July 1, 2018 There are three "key components" used to determine levels of Evaluation and Management (E/M) services. The
This month’s news from across the specialty
What’s hot ... March 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Bryan Carroll, MD, PhD, FAAD New, but not new, but maybe new, but not good = ... Candida auris is looking worse with
April 17, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 17, 2024 ... Does low-dose oral minoxidil improve short anagen syndrome? DermWorld Insights and Inquiries : Weighing in on glucagon-like peptide-1 receptor agonists in dermatology CDC investigates counterfeit botox: AAD
Americans with Disabilities Act issues in dermatology
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, D.C. ... By Ben Tesdahl, JD, Megan La Suer, JD, MHA, and Robert M. Portman, JD, MPP, January 1, 2021 Every month, DermWorld ... covers legal issues in "Legally
Long COVID has a lot of nerve
By Warren R. Heymann, MD, FAAD Dec. 17, 2025 Vol. 7, No. 49 The profound medical and socioeconomic trauma of the COVID-19 pandemic may seem as though it is in the rearview mirror, but it is not. As of April 15, 2025, the CDC estimated that COVID-19 infections are growing
Challenges ebb and flow, but our “why” remains the same
From the President ... Dr. Kaufmann served as Academy president from March 2022 to March 2023. ... By Mark Kaufmann, MD, FAAD, March 1, 2023 Serving as your Academy President these last 12 months has been a journey filled with opportunities and challenges. While it has been a test of
Cosmetic or not, will this be covered?
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, February 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Dermatologists play a crucial role in
Primer on payer contract issues
Answers in Practice ... By Lou Terranova, Associate Director, Practice and Payment Policy, and Teresa Salaway, Senior Manager, Practice and Payment Policy, October 1, 2024 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, AADA regulatory and payment policy staff highlight critical elements of payer contracts for
May 10, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 10, 2023 ... Is spironolactone use for acne associated with increased risk for venous thromboembolism? DermWorld Insights and Inquiries : PRAME sets its eyes on the road to fame How
Indoor tanning fact sheet
Indoor tanning use ... The global prevalence of indoor tanning in adolescents for 2013-2018 was 6.5%, and 10.4% in adults. (1) ... Though the numbers have been decreasing in recent years, approximately 7.8 million adults in the U.S. still engage in indoor tanning. (2,3) ... Among high school students in
Lock it down
Answers in Practice ... By Victoria Houghton, Managing Editor, September 1, 2020 Dermatology World ... talks to Jon Ward, MD, founder and president of Dermatology Specialists of Florida, about developing office lockdown procedures. Dermatology World: You have procedures for several emergency events — not only natural disasters, but also for
2026 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... May ... May 1 - Granular C3 dermatosis in granular detail April ... April 1 - Cocaine-associated plasma cell orificial mucositis: Anything goes March ... March 1 - Eosinophilic pustular folliculitis: Six decades of progress February ... Feb. 1
Go your own way
Dermatologists share experiences and considerations practicing in a variety of practice models. ... Feature ... By Allison Evans, Assistant Managing Editor, September 1, 2025 Whether you’re embarking on your career path, or you’re simply ready for a reset, there are a multitude of practice models to investigate. Each path offers
What's hot?
What's hot ... January 29, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... Many of us struggle with patients with refractory pruritus who have tried many combinations of antihistamine, tricyclic,
This month’s news from across the specialty
What’s hot ... October 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD, FAAD Chronic pruritus is burdensome for patients with chronic kidney disease (CKD) and can be incredibly difficult for dermatologists to
I always knew firefighting was a dangerous occupation
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, FAAD, March 1, 2023 I grew up in a very small town where firemen, all of whom were volunteers from the community, were called to action with a very loud siren that
Shielding our heroes: Dermatologists deploy to provide free skin cancer checks to 425 NYC firefighters
Event kicks off the American Academy of Dermatology’s and Firefighter Cancer Support Network’s national program to check 10,000 firefighters for skin cancer by 2026 NEW YORK CITY (May 28, 2024) — The American Academy of Dermatology (AAD), in conjunction with the Firefighter Cancer Support Network, will host a free Skin
JAAD impact factor ranks No. 1 among dermatology journals
JAAD International debuts at No. 10 ROSEMONT, Ill. (June 19, 2025) — The ... Journal of the American Academy of Dermatology remains the top peer-reviewed journal in its field for the sixth straight year, according to the 2024 journal impact factor (JIF) rankings recently published by ... Clarivate’s Journal Citation
Prognosticating folliculotropic mycosis fungoides: Everything old is new again
By Warren R. Heymann, MD Sept. 16, 2016 I was dermatology resident in 1980 learning about mycosis fungoides when the late Peter Allen was in his glory singing "Everything Old is New Again". The universe of cutaneous T cell lymphoma was simultaneously more confusing (how would you differentiate poikiloderma
My core incompetencies
By Warren R. Heymann, MD May 19, 2017 It is time for our semiannual ritual — the meeting of our Clinical Competency Committee (CCC). Our dermatology program is small, having twice as many faculty members as residents, so everyone serves on the committee. The process has changed dramatically from the
Managing Gen Z patients
Answers in Practice ... By Emily Margosian, Assistant Editor, March 1, 2023 DermWorld ... talks to Brittany Craiglow, MD, FAAD, from Yale School of Medicine, about tips for managing Gen Z patients — individuals born after 1996. DermWorld: Tell us about your practice. Brittany Craiglow, MD, FAAD ... Dr. Craiglow:
Rapalogs for vascular lesions: Caveat mTOR
By Warren R. Heymann, MD Sept. 21, 2016 Rapalogs are drugs that inhibit the mTOR pathway and include sirolimus (rapamycin), temsirolimus, everolimus, and deforolimus. All are immunosuppressive and have antineoplastic/antiproliferative effects. The mTOR protein is a serine-threonine kinase involved in complex intracellular signaling pathways affecting the key processes of cell
Aluminum can cause allergic contact dermatitis: Allergen of the Year 2022
By Christen Mowad, MD, FAAD June 15, 2022 Vol. 4, No. 24 Allergen of the year is an eagerly awaited award for those of us excited by allergic contact dermatitis. It has been given each year for over 20 years to highlight allergens of new and emerging significance and sometimes
A second set of eyes
As states consider new chaperone rules for skin checks, what do they mean for your patients and practice? ... Feature ... By Emily Margosian, Senior Editor, July 1, 2025 In dermatology, the physical exam is a core part of nearly every patient encounter, requiring mutual trust between patient and physician.
Impact Report — Vol 4, Issue 1
Celebrating a year of big wins at the Academy From critical changes to iPLEDGE, to new CME learning opportunities on actinic keratosis, alopecia, and atopic dermatitis, to enhanced coding and practice management tools, the Academy was here for you in 2023. Our successes are a direct result of the strong
Impact Report — Vol 3, Issue 1
We are building a brighter tomorrow, today. Our bright tomorrow is forged and reinforced by the work we do all year to make the Academy strong. The efforts and successes involve AAD staff, working alongside leadership and, importantly, members like you. It’s a powerful collaboration. ... In this edition of
1984: Dermatologically revisited
By Warren R. Heymann, MD Aug. 22, 2018 George Orwell published ... Nineteen Eighty-Four in 1949. I started my dermatopathology fellowship at the University of Pennsylvania in 1984. I decided to review ... Archives of Dermatology (now ... JAMA Dermatology ), looking back 34 years to see how the dermatologic
Linear and whorled nevoid hypermelanosis: Past reflections and future directions
By Warren R. Heymann, MD July 4, 2017 Linear or circular arrangement of pigmented macules along the lines of Blaschko. ... Credit: ... JAAD I recall meeting Debra Chester Kalter as a young, remarkable dermatologist, chatting annually with her at the AAD meeting. She was my wife’s classmate at the
Hiring high-quality clinical and non-clinical staff
In Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, August 1, 2018 Every aspect of a physician practice is important to delivering the highest quality of care to
"Insure"
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, FAAD, September 1, 2024 "To make certain especially by taking necessary measures and precautions." ( ... www.merriam-webster.com/dictionary/insure .) In the past few years, ... DermWorld has shared stories from colleagues who have
The importance of cross-training and preparing for change
Change, as they say, is the only constant we can count on, but change can be difficult to accept and adapt to if you are not prepared. A successful practice should always be thinking "how will you and your team manage change?" By planning for change, you are not only
A metabolic pathway that may allow dermatologists to run rings around porokeratoses
By Warren R. Heymann, MD July 31, 2019 Vol. 1, No. 21 "I know the variants of porokeratoses and can recite them as though I am the very model of a modern major general — Mibelli, linear, punctate, palmoplantar, DSAP [disseminated superficial actinic porokeratosis], superficial disseminated, immunosuppression-related, and porokeratosis ptychotropica.
August 13, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 13, 2025 ... Effects of GLP-1RA on inflammatory skin diseases DermWorld Insights and Inquiries : Sweating over sweat gland carcinomas: Part 1 — Squamoid eccrine ductal carcinoma Beta-HPV virus can
2026 Final Medicare Physician Fee Schedule
CMS finalized a nominal increase in physician payment rates in the 2026 Medicare Physician Fee Schedule (MPFS) Final Rule. While this update helps avert another payment reduction, the adjustment remains inadequate to keep pace with escalating practice costs and inflation. The AADA continues to advocate for comprehensive Medicare payment reform
Elmer Fudd beware: Tularemia’s re-emergence
By Warren R. Heymann, MD Sept. 24, 2018 Ulcer on left thumb of patient with ulceroglandular tularemia. ... Credit: ... JAAD Practicing dermatology is humbling business. I tip my hat to Polat et al, who diagnosed tularemia in an 11 year-old girl presenting with targetoid papules and plaques of her
2022 simple repair guideline updates
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Coding & Reimbursement, December 1, 2021 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . The Integumentary System, Repair (Closure) guidelines have been
This month's news from across the specialty
What's hot ... April 1, 2020 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... MALLORY ABATE, MD Interested in some patch testing pearls for your patients with allergic contact dermatitis? In the January issue of ...
Desquamative gingivitis: Sinking your teeth in miagnosis and management
By Warren R. Heymann, MD Jan. 7, 2017 Cycle of oral hygiene in desquamative gingivitis. ... Credit: ... JAAD Patients presenting with desquamative gingivitis (DG) are typically some of the most frustrated, aggravated patients I encounter. Frequently, they have not been adequately evaluated, are in pain, and are desperate for
January 24, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 24, 2024 ... Micrographic vs. conventional excision: Reducing rates of BCC, SCC DermWorld Insights and Inquiries : Senile gluteal dermatosis — The term ‘senile’ is getting old and should be
Educating the public — 2020 snapshot
In 2020, we pivoted our communications efforts to better respond to the real-time needs of the public brought on by the pandemic. While we shifted our efforts, our goal of positioning dermatologists as the experts — even during unprecedented times — never changed. By adapting our traditional messaging to resonate
A big, fat lie
By Warren R. Heymann, MD Feb. 17, 2019 At my heaviest, circa 1997, with my daughters Andrea, Deborah, and our (sorely missed) late puppy Heidi. ... "Packing on the pounds, aren’t you, doc?" ... What a lovely greeting that patient gave me that morning more than twenty years ago.
2024 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... Dec. 17 - DWI&I Holiday Greeting 2025 Dec. 11 - Idiopathic granulomatous mastitis joins the pantheon of erythema nodosum-associated disorders Dec. 4 - Darier disease is rough clinically and therapeutically. MEK inhibition may offer a smoother future
CLIA in 2025: What dermatology practices need to know now about the updated laboratory requirements
Answers in Practice ... By Faiza Wasif, MPH, Associate Director, Practice Management, August 1, 2025 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff discuss what dermatology practices need to know about the updated laboratory requirements. Whether your office does potassium hydroxide (KOH) preps,
This month’s news from across the specialty
What’s hot ... July 1, 2022 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD, FAAD Social media can be a very useful tool for practices to grow their practice population, and has become a
This month’s news from across the specialty
What’s hot ... April 1, 2026 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Ken Katz, MD, MSc, MSCE, FAAD Immune checkpoint inhibitors (ICIs) have dramatically improved prognosis for melanoma and other cancers. Once nearly always fatal, advanced
This month’s news from across the specialty
What’s hot ... May 1, 2026 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Jason Lee, MD, FAAD The incidence of melanoma in situ has increased to epidemic proportions, rising 50-fold since 1975. Lentigo maligna is the most
Naltrexone therapy for Hailey-Hailey disease: Confirming my addiction to evidence-based medicine
By Warren R. Heymann, MD Aug. 28, 2017 Hailey-Hailey disease. Patient 1: erythematous-crusted plaques on the lower midback before radiation treatment. ... Credit: ... JAAD I was fascinated by a presentation at the recent World Congress of Pediatric Dermatology discussing improvement of epidermolysis bullosa wounds with topical CBD (cannabis) oil.
July 5, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 5, 2023 ... Petroleum jelly: Safety, myths, and misconceptions DermWorld Insights and Inquiries : Reflections on reflectance confocal microscopy for diagnosing benign lichenoid keratoses Managing CLE with JAK inhibitors Homelessness